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8 Chapter 1 
There is no treatment that can cure any type of dementia or even halt its progression, nor is such 
a treatment expected to become available in the near future.1,2 Optimising the quality of life of 
both patients and their informal carers is one of the most important treatment goals in dementia 
care, and psychosocial care is essential to this process. Nevertheless, the implementation of 
evidence-based psychosocial dementia care, which is limited in Europe, needs to be encouraged. 
This thesis is about the development of a set of quality indicators (QIs) to help implement 
evidence-based psychosocial dementia care in European countries. This general introduction 
provides information about the dementia syndrome, the scientific evidence for pharmacological 
and psychosocial interventions in dementia care, and the role of QIs in improving the quality of 
health care.  
 
Dementia syndrome 
Dementia is one of the leading contributors to the burden of disease in Europe.3 The estimated 
number of people with dementia in European countries is more than 7 million, of whom 235,000 
are living in The Netherlands.4,5 Numbers of cases in both Europe and The Netherlands are 
expected to double by 2050.4,5  
Dementia is a clinical syndrome with a progressive course that is characterised by a continuous 
decline of cognitive functions and abilities of the patient to independently perform activities of 
daily living, such as dressing, bathing, toileting, and eating. This decline is often accompanied by 
various behavioural and psychological symptoms, such as agitation, apathy, aggressiveness, 
wandering, sleep disturbances, and anxiety.6,7 These cognitive, functional, behavioural, and 
psychological symptoms can make living with and caring for a person with dementia burdensome 
for family and other informal carers.8  
Although most Europeans with dementia are cared for at home, institutionalisation is often 
inevitable as the disease progresses.5,9 Elderly people with dementia are more likely to live in a 
long-term care facility at some point than elderly people without dementia.10 A study in five 
Western European countries has found that most people with dementia die in a long-term care 
facility.11 
 
Pharmacological interventions in dementia  
The interventions that are available for dementia focus on postponing cognitive decline as long as 
possible, alleviating behavioural and psychological symptoms during the course of the disease, 
and alleviating informal carers’ stress. Pharmacological interventions with cholinesterase 
inhibitors and memantine have shown little efficacy in postponing cognitive and functional 
decline, but these findings are only for specific types and stages of dementia. Further, these anti-
dementia drugs are not tolerated by all people with dementia.12-15 A Cochrane review has shown 
that people with dementia treated with cholinesterase inhibitors had more adverse events (29%) 
than people with dementia receiving placebo (18%). Nausea, vomiting, and diarrhoea were 
significantly more frequent among people with dementia being treated with cholinesterase 
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inhibitors.12 The number of adverse events was low in people with dementia treated with 
memantine, but its use could be justified only for the moderate to severe stages of one specific 
type of dementia, namely Alzheimer’s disease.13  
The value of the improvements that these anti-dementia drugs achieve is debatable. Some 
conclude that the effects are clinically unimportant or marginal at most.15,16 Others conclude that 
anti-dementia drugs can benefit people with dementia, that long-term treatment is effective in 
stabilising cognitive function, and that withholding treatment from people with dementia would 
be unethical.12,17,18  
Studies about the efficacy of the drug therapies that are used to treat behavioural and 
psychological symptoms of dementia show small or inconclusive effects. In addition, the safety of 
these drugs has been questioned.7,19-25 A meta-analysis of the effects of atypical antipsychotic 
drugs shows that the mortality rate was higher among people with dementia treated with these 
drugs than among those given placebo: OR 1.54 (95% CI 0.004 to 0.02).21 The use of these drugs 
for a relatively short time, 8-12 weeks, had already been associated with a small, but increased, 
risk of mortality.21 The specific drug risperidone was associated with an almost four times greater 
risk of serious cerebrovascular adverse events, including stroke: OR 3.64 (95% CI 1.72 to 7.69).26 
Notwithstanding the debate about the clinical value and the safety issues, pharmacological 
interventions are monitored closely and people with dementia and their carers are seen on a 
regular basis. This provides the opportunity of hearing them and giving attention to their 
problems.  
 
Psychosocial interventions in dementia  
Psychosocial interventions are non-pharmacological approaches that are behaviour oriented, 
emotion oriented, cognition oriented, or stimulation oriented, and involve interaction between 
people.27,28 Psychosocial interventions aim to improve the quality of life, and psychological and 
social functioning, and to maximise function in the context of existing deficits.27,28 A variety of 
psychosocial interventions are available for both people with dementia and informal carers 
(Table). 
The evidence base for these types of interventions in dementia care has grown quickly during the 
last decade.29 Various psychosocial interventions have proven to be safe and effective treatment 
options.30-36 The results of a randomised, controlled trial investigating a cognitive stimulation 
programme for people with dementia were comparable to the results of treatment with 
cholinesterase inhibitors for improving cognitive functioning. The cognitive stimulation 
programme produces no adverse events and has no restrictions to the type of dementia.30,37 
Occupational therapy interventions also have positive effects.33,38-40 A Dutch intervention 
programme of occupational therapy for people with dementia and their carers who live in the 
community improved patients’ daily functioning and was cost-effective compared to usual home 
care.33,40 However, a German study did not find similar effects for the same occupational therapy 
intervention.41  
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Systematic reviews of the effectiveness of psychosocial interventions have found that exercise 
has positive effects on the physical, cognitive, functional, and behavioural outcomes. They have 
also found that the use of sensory-focused strategies have short-term positive effects on 
behavioural and psychological symptoms of people with dementia.31,32,34 Psychosocial 
interventions, in general, are most effective when they are tailored to the patient’s background 
and preferences.7,35,36 
Informal carers of people with dementia also benefit from psychosocial interventions. In their 
systematic reviews, both Brodaty et al. and Pinquart and Sörenson found that support 
programmes for informal carers can reduce their psychological morbidity and feelings of burden. 
Such programmes also improve their subjective well-being and knowledge.42,43 A recent 
Cochrane review finds significant benefits of cognitive reframing interventions on the 
psychological morbidity, depression, and subjective stress of informal carers.44 Tailored, 
structured, and multicomponent interventions aimed at both informal carers and people with 
dementia can delay the institutionalisation of the patients.29,42,43,45,46 
Besides evidence for the effectiveness of specific psychosocial interventions, there is also 
evidence available about the principles of psychosocial dementia care in general. This is largely 
based on best practice and psychosocial theories and models that try to explain the perspective 
of both the person with dementia and the carers. Specific psychosocial interventions are often 
based on these theories and models.  
One of the central features of psychosocial dementia care is the preservation of personhood, 
which is reflected in person-centred care for people with dementia.55-57 Furthermore, 
psychosocial dementia care should promote the well-being and quality of life of a person with 
dementia and their carer at any stage of the disease while taking the existing deficits into 
account. In essence, providing psychosocial dementia care includes meaningful interaction and 
communication with the person with dementia, awareness of their possible needs, preservation 
of their dignity and autonomy, and social inclusion of both the person with dementia and their 
carer.28,55,58-61 The use of specific psychosocial interventions is essential to psychosocial dementia 
care. 
 
Psychosocial dementia care in Europe 
Psychosocial interventions are recommended as the first treatment option for various symptoms 
of dementia.7,24,47 Despite this fact, much uncertainty still exists about the availability of 
psychosocial interventions and the use of psychosocial dementia care across Europe. 
Psychosocial dementia care does not seem to be appreciated in the same way and does not seem 
available on the same scale as medical and pharmacological care. Anti-dementia drugs are 
available in most European and other Western countries, whereas effective psychosocial care 
remains under-promoted.9,62,63 Psychosocial interventions are recommended less often than 
pharmacological interventions, their limited availability being one of the reasons.64,65 To improve  
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the quality and availability of psychosocial dementia care in Europe, its implementation needs 
encouragement.  
 
Table. Examples and descriptions of psychosocial interventions for people with dementia and their informal 
carers 
 
Target group Treatment Description 
People with 
dementia 
Cognitive stimulation 
Reality orientation  
Exposure to and engagement with activities and materials involving some 
degree of cognitive processing, usually within a social context. The intervention 
is often group-based, with the emphasis on enjoyment of activities.
47
 
 Cognitive training Training exercises geared to specific cognitive functions, and practice and 
repetition of these exercises; a range of difficulty levels may be available 
within the standard set of tasks to suit the individual’s ability. May be offered 
in individual or group sessions.
47,48
 
 Environmental 
interventions 
The creation of safe and secure, simple, well-structured, and familiar 
environments that provide cues, support in daily activities, and privacy for 
people with dementia.
49
 
 Physical activity 
Exercise training 
Exercise programme or form of rehabilitative exercises, physical activity, 
fitness, or recreational physical therapy.
31
 
 Reminiscence  Regular individual sessions or meetings of small groups involving the discussion 
of past activities, events, and experiences, possibly aided by means such as 
photographs, music, and videos of the past, household and other familiar 
items from the past.
50
  
 Sensory stimulation 
Snoezelen 
 
Providing sensory stimuli to the primary senses of sight, hearing, touch, taste, 
and smell through the use of lighting effects, tactile surfaces, meditative music 
and the odour of relaxing essential oils.
51
 
 Validation The acceptance of the reality and personal truth of another’s experience. 
Providing a high degree of empathy and an attempt to understand a person 
with dementia’s entire frame of reference. The approach can be used as a 
structured therapeutic activity in a group setting or it can be used on an 
individual basis.
47,52
  
Informal 
carers 
Cognitive reframing  Group or individual programmes to alter maladaptive, self-defeating or 
distressing cognitions of informal carers relating to their beliefs about their 
responsibilities to the person with dementia, their own need for support, and 
why their relatives behave as they do; and to make them more adaptive to the 
caring situation.
44
  
 Psycho-education Programmes for individuals or groups of informal carers that involve learning 
how to react to and interact with a person with dementia.
47
  
 Respite care Any service or group of services designed to provide temporary periods of 
relief and/or rest for informal carers, ranging from a couple of hours to a 
number of weeks. It can take place in the home of the person with dementia, a 
daycare centre, or a residential setting and may be provided by trained or 
untrained staff or volunteers.
53
  
 Support groups Group sessions led by professionals that can provide mutual support, 
information, and education.
54
  
People with 
dementia and 
informal 
carers 
Occupational therapy People with dementia and informal carers learn compensatory strategies to 
improve the ability to perform activities of daily living, promoting 
independence, participation in social activities, and increasing the carer’s sense 
of competence.
33
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Quality indicators to improve the quality of psychosocial dementia care  
An important step in any effort to implement scientific evidence in practice and hence, improve 
the quality of health care, is the development of clinical practice guidelines and QIs.66 Clinical 
practice guidelines assist health care professionals in making decisions about appropriate health 
care for diseases or conditions.67 They state the ‘right thing to do’ in specific clinical 
circumstances on the basis of the best available scientific evidence.66,68 Quality indicators are 
explicitly defined and measurable elements of practice performance for which there is evidence, 
or at least consensus, that they can be used to assess improvement and change in the quality of 
care provided.66,68-70 Whereas guidelines help professionals to decide during the provision of 
care, QIs are used to measure adherence to clinical guidelines and to measure, monitor, and 
improve the quality of care provided by health care professionals and organisations.68,70,71 
 Quality indicators are most often expressed as a numerator and a denominator. The numerator 
usually describes the number of correct or desired health care actions within the target 
population. The denominator usually describes the size of the target population.66 Based on 
Donabedian’s framework for assessing the quality of health care, a quality indicator usually 
describes and assesses one of the following aspects of care: structures, processes, or 
outcomes.66,71-73 Quality indicators that focus on structures of care refer to the organisational 
aspects of service provision; QIs that focus on processes of care refer to the actual care delivered 
to and negotiated with patients; QIs that focus on outcomes of care refer to the ultimate goal of 
the care given.66,72-74 In general, the use of process indicators is important for achieving quality 
improvement in health care. Outcome indicators are more often used for purposes of external 
accountability.66,68 
Developing a European set of QIs for psychosocial dementia care would enable European 
dementia care professionals to measure their practice performance and improve the quality of 
the psychosocial care they provide in daily practice. Such a set of QIs should include measurable 
key elements for providing psychosocial interventions based on scientific evidence and dementia 
guidelines, and the set should capture the essence of psychosocial dementia care in general. 
European sets of QIs have already been developed for measuring the quality of general practice 
management and cardiovascular care in European countries.75-77 
 
Developing a set of quality indicators  
A set of QIs can be based on existing sets of QIs, recommendations from evidence-based clinical 
guidelines, scientific evidence from literature, best practice, consensus among experts, or a 
combination of these.66,68,70 The developers of a set of QIs should consider whose perspective the 
QIs should reflect, which aspects of care should be assessed, and what evidence is available.68,70 
Ideally, QIs are based on high-quality scientific evidence that increases their potential to improve 
the quality of health care.66,68,70 However, evidence bases are limited for most health care areas, 
and consensus among experts in the field needs to be included in the development. Consensus 
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techniques that are often used for developing QIs are the Delphi technique, the RAND 
appropriateness method, and the Rand-modified Delphi technique.66,68,70  
Face and content validity of QIs and their adherence to characteristics such as applicability, 
measurability, reliability, sensitivity to change, and predictive validity are required to maximise 
the potential of a set to improve the quality of health care.66,68,70 Face and content validity is the 
minimum prerequisite for QIs and concerns the extent to which QIs accurately represent the 
concept they are supposed to measure. The use of expert panels and clinical guidelines during 
development leads to QIs with high face validity. Sets of QIs based on rigorous evidence have 
high content validity. Adherence of the QIs to characteristics relating to their application and 
feasibility in practice should be established with empirical evidence.66,68,70 
 
Developing European quality indicators for psychosocial dementia care  
The development of a set of QIs for psychosocial dementia care on a European level was one of 
the aims of the European Collaboration on Dementia project (EuroCoDe, 2006–2008), which was 
initiated and led by Alzheimer Europe.62 This thesis about the development of QIs for 
psychosocial dementia care was produced as part of this project.  
The process of developing the European set of QIs had to fit into the 3-year time frame of the 
EuroCoDe project. Basing the QIs on existing sets of QIs would have been the most time efficient, 
but the sets of QIs for dementia care already developed and published focus mainly on 
diagnostics, screening, and pharmacological treatments.78-81 Quality indicators for psychosocial 
dementia care were not yet available and needed to be newly developed. 
The principal stakeholders of the set of QIs were European dementia care professionals and their 
perspectives on quality of psychosocial dementia care had to be represented by the QIs. As our 
goal was to encourage quality improvement of psychosocial dementia care, processes of care 
seemed the most appropriate entities to assess with the QIs.66,68 High-quality scientific evidence 
is still limited for specific psychosocial interventions and psychosocial dementia care in general, 
and consensus among European dementia experts was needed for the development of the 
QIs.66,68,70 We used a step-wise procedure for developing the QIs to attain face and content 
validity, measurability, and applicability of the set. The procedure was built on scientific evidence 
from literature and dementia guidelines, consensus among European dementia care experts, and 
a small-scale pilot study to test the QIs in practice.  
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Aims and outline of this thesis 
 
Aims and research questions 
The primary aim of this thesis was to describe the development and evaluation of a set of QIs for 
psychosocial dementia care. More specifically, this set of QIs should be: 
• Representative of the standard of psychosocial dementia care based on scientific evidence, 
best practice, and theories and models of psychosocial care. 
• Applicable to people with dementia and their carers in various European countries.  
• Measurable in and applicable to the various settings where dementia care is provided in 
various European countries. 
 
The following research questions were formulated and used to develop and evaluate the 
European set of QIs for psychosocial dementia care: 
1. What gaps exist in the evidence base for psychosocial dementia care, and can these gaps be 
filled on the basis of the available evidence? 
2. To what extent is evidence for psychosocial dementia care included in European dementia 
guidelines for care professionals? 
3. What evidence-based key elements represent psychosocial dementia care of good quality and 
therefore should be included in the set of QIs?  
4. Is such a set of QIs applicable to people with dementia and their carers in various European 
countries? 
5. Is such a set of QIs measurable in and applicable to different settings where dementia care is 
provided? 
6. What are the barriers and facilitators in implementing such a set of QIs in various European 
countries?   
 
Outline of this thesis 
This thesis describes the various steps in the process of developing the set of QIs for psychosocial 
dementia care. Each of the Chapters 2 to 5 addresses one or more of the above-mentioned 
research questions.  
First, a review of systematic reviews was conducted. This identified a paucity of literature reviews 
that specifically aim at the effectiveness of psychosocial interventions for people with dementia 
living in residential and nursing homes.82 A systematic review was therefore conducted to study 
the effects of these types of interventions in residential and nursing homes on the 
communication between residents with dementia and care staff, and the neuropsychiatric 
symptoms of residents. Chapter 2 presents the results and conclusions of this systematic 
literature review.  
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Second, the dementia guidelines that are available in European countries were inventoried. 
Chapter 3 presents the results of the inventory, a comparison of the methodological quality, and 
the recommendations for speciﬁc psychosocial interventions in these guidelines. 
Third, the available evidence from the literature and recommendations from evidence-based 
dementia guidelines were used to conduct a RAND-modified Delphi procedure that included two 
dementia expert panels. The purpose of this was to achieve content and face validity of a 
potential set of QIs. Dementia care professionals from various European countries then discussed 
these QIs face to face and tested them in practice. In addition, the measurability and applicability 
of the set of QIs were tested in various dementia care settings in Spain and The Netherlands. 
Chapter 4 presents the results of this work and the final set of QIs for psychosocial dementia 
care. 
Fourth, focus-group interview sessions were used in a qualitative study to explore the barriers 
and facilitators in implementing the final set of QIs in various European countries. A purposive 
sample of 27 dementia care professionals from nine European countries and various disciplines 
was included. A model of barriers and facilitators for change at six levels of health care was used 
as a framework for organising the data. Chapter 5 presents the results of this study and the 
proposed implementation strategy. 
Finally, Chapter 6 discusses the stepwise process of developing and evaluating the set of QIs for 
psychosocial dementia care and its importance for dementia research and practice. 
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Abstract 
Introduction: The impairment of verbal skills of people with dementia challenges communication. 
The aim of this review was to study the effects of nonpharmacological interventions in residential 
and nursing homes on (1) communication between residents with dementia and care staff, and 
(2) the neuropsychiatric symptoms of residents with dementia. 
Methods: Pubmed, PsychInfo, Web of Science, the Cochrane Library, and reference lists from 
relevant publications were systematically searched to find articles about controlled interventions 
with communication strategies. The data collected were pooled and subjected to a meta-analysis. 
Results: Nineteen intervention studies were selected for this review. They included structured 
and communicative “sessions at set times” for residents (e.g. life review) and communication 
techniques in activities of “daily care” applied by care staff (e.g. sensitivity to nonverbal 
communication). A meta-analysis of five set-time interventions (communication) and another 
meta-analysis of four set-time interventions (neuropsychiatric outcomes) found no significant 
overall effects. Individual set-time intervention studies report positive effects on communication 
when interventions are single-task sessions, like life review or one-on-one conversation. 
Interventions around daily care activities had positive effects on communication outcomes. 
Effects of both types of interventions on neuropsychiatric symptoms were divergent. 
Conclusion: This review indicates that care staff can improve their communication with residents 
with dementia when strategies are embedded in daily care activities or interventions are single-
task sessions at set times. These results offer the possibility of improving the quality of care, but 
not of directly reducing neuropsychiatric symptoms. More research is needed to study the effect 
of communication interventions on neuropsychiatric symptoms. 
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Introduction 
Currently, about 2 million Europeans are diagnosed with dementia every year.1 Most of these 
people continue to live in the community, but various cognitive and neuropsychiatric symptoms 
become more pronounced as the disease progresses and contribute to placement in 
institutionalised care.2,3 Although intensive support programs for people with dementia and their 
carers can delay institutionalisation4, about 70% of these people in the Netherlands are 
eventually placed in a residential or nursing home.5  
While caring for one person with dementia can be a difficult task, caring for a group of patients 
can be a real challenge. Neuropsychiatric symptoms are very common, and more than 80% of the 
cognitively impaired nursing-home residents in the Netherlands have at least one clinically 
significant neuropsychiatric symptom.6 The most frequently observed behaviours (prevalences of 
30–35%) are aggression/agitation, apathy, and irritability. In other countries, similar incidences of 
these behaviours occur among people with dementia whether they are institutionalised or not.7,8 
Care staff find it difficult to cope with the aggressive, hostile, stubborn, resistant, and 
unpredictable behaviour of residents9, so that working with cognitively impaired people is 
associated with much stress.10 
Unmet needs can trigger neuropsychiatric symptoms11, as can language disorders12, discomfort, 
or pain. The residents’ impaired communication skills make it very difficult for care staff to 
identify and address the source of the disturbed behaviour. 
Antipsychotic drugs are frequently used in dementia care to treat neuropsychiatric symptoms13, 
but these medications only relieve the symptoms and do not treat the underlying causes of the 
behaviour. Furthermore, these drugs are known to cause serious side effects (e.g. stroke or 
increased mortality rates), and are not suitable for routine use.14 Nonpharmacological 
interventions are preferred to drugs in the treatment of neuropsychiatric symptoms. 
Interventions therefore need to be investigated to encourage and ease communication between 
care staff and residents. Communication is achieved by speech, writing, gesture, posture, gaze, 
affect, and intonation. These are specific to the place and purpose, or the context, of the 
communication. Care staff need to be aware of how residents signal the need to communicate 
and how to react to the signals. 
Several reviews about the use of nonpharmacological interventions in dementia care have 
recently been published15-17, but these do not focus on people with dementia in institutional care 
or the effects of communication strategies on neuropsychiatric symptoms. 
The aims of this systematic review were to appraise (1) the effectiveness of communication 
enhancing interventions for the care staff and/or residents with dementia in institutional care 
settings, and (2) the effects of these interventions on neuropsychiatric symptoms. 
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Methods 
Search strategy 
We searched Pubmed, PsychInfo, and Web of Science (1980–February 2007) for controlled, 
nonpharmacological, intervention studies that included institutionalised people with dementia 
and/or care staff. The following search strategy was used: 
•  (communication OR interaction) 
•  AND (nursing homes OR nursing home OR residential facilities OR residential facility OR 
hospitals OR hospital OR institutionalized OR institutionalised OR inpatient OR inpatients OR 
long-term care OR geriatric nursing OR in-patients OR patients OR residents OR ward OR 
wards OR “care unit” OR “care units” OR residential OR “assisted living” OR in-patient) 
•  AND (vascular dementia OR lewy body disease OR alzheimer’s OR alzheimer OR “Alzheimer 
Disease” [MeSH] OR “Lewy Body Disease” [MeSH] OR “Dementia, Vascular”[MeSH] OR 
“Dementia” [MeSH: noexp]) 
•  AND (controlled OR trial).  
We also identified trials in an additional search of the Cochrane Library in February 2007 using 
the words Dementia [MESH] AND interact∗ OR communicat∗, and we reviewed the references of 
the studies we included to identify any other relevant studies. 
 
Inclusion criteria 
The studies to be included in this review had to meet all of the following criteria: 
1. Type of study: a randomised or nonrandomised controlled trial with the full text obtainable in 
English or Dutch. A randomised or nonrandomised controlled trial was defined as a study that 
compared the results from the intervention group to the results from one or more comparison 
groups receiving the usual intervention or no intervention at all; or a standardised, 
comparable intervention without the communication component. 
2. Participants: people with dementia living in residential care homes or in nursing homes and/or 
professional carers working in long-term care facilities with people with dementia. The 
inclusion criteria for the trial required a diagnosis of dementia or screening for cognitive 
impairment of resident participants. If groups of residents were mixed with nonresidents, at 
least 80% of the participants had to be residents or else their separate results needed to be 
available. 
3. Intervention: an intervention aimed at improving the communication of participants. Multi-
component interventions had to include a communicative component. Communication was 
defined as sharing information by speaking, writing, body movements, or other signalling 
behaviour. 
4. Outcomes: at least one outcome measure was required to address the quantity and/or quality 
of communication performance or else no productive communication (e.g. apathy or 
noncompliance) of the participants. 
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Reviews of trials, pharmacological interventions, and studies in which the participants served as 
their own control group were excluded. 
 
Screening the studies 
Two independent reviewers (EV and MVD) assessed the candidate studies for inclusion in three 
screening rounds. During the first round, they screened articles by title and type of article to 
determine whether they met the inclusion criteria. In the second round (abstracts) and the third 
round (full text), they screened the remaining articles if the abstract or full text was available. 
Studies that failed to meet the inclusion criteria were excluded. In cases of doubt, the articles 
were included in the next review round. 
 
Quality of the studies 
Two researchers (EV and AS) assessed the methodological quality of the studies independently 
and discussed the results for consensus. They assessed the following criteria, after Higgins and 
Green18, to check for differences in methodological quality between studies: selection bias 
(method of randomisation, allocation concealment, inclusion/exclusion criteria specified, and 
similarity of groups at baseline), performance bias (assessors blinded to outcome), attrition bias 
(characteristics of participants lost to follow-up described, and intention-to-treat analysis), and 
detection bias (power calculation and valid outcome measures). Blinding of participants was not 
included as a quality criterion because it is impossible for the types of interventions included in 
this review. 
 
Data collection and analysis 
First, the characteristics of the interventions and outcome measures used for communication and 
neuropsychiatric symptoms were extracted from the articles. The interventions were then sorted 
by type so that we could extract their effectiveness on communication and neuropsychiatric 
symptoms, when data were available. 
We performed a meta-analysis using the Cochrane Collaboration Group’s Review Manager 5 (The 
Cochrane Collaboration, Copenhagen, Denmark) when two or more studies were randomised 
controlled trials and the outcome measures and type of intervention could be compared. 
Because of the continuous nature of the data and differences in the outcome measures used, we 
calculated a standardised mean difference (SMD), which is a uniform standardised score, to 
compare the data from experimental groups with the data from the control groups. We 
calculated SMDs (for the experimental group and the control group) as the difference between 
the mean change in communication or neuropsychiatric symptoms, before and after the 
intervention, divided by the standard deviation of the difference. 
If a measurement was repeated, the data from the first measurement after the intervention were 
used as post-intervention data in the meta-analysis. In case multiple intervention and/or control 
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groups were included in a study, these groups were combined and included as a single group in 
the meta-analysis.18 
Statistical significance was set at p<0.05. We set up a fixed-effects model for each meta-analysis. 
If the statistical heterogeneity, as calculated by the I2 statistical test, was significant ( p<0.05), the 
analyses were repeated with the random-effects model.18,19 Significant between-group effects 
for both communication or neuropsychiatric symptoms of intervention studies that could not be 
included in the meta-analyses were described separately for each type of intervention study. 
 
Results 
Search results 
The search retrieved 721 articles that met the search criteria. After we excluded reviews and 
pharmacological trials, 488 articles remained. The first screening round resulted in 85 titles of 
articles that met the inclusion criteria or raised doubt. We screened the abstracts of these 85 
articles, and 35 articles remained for full-text assessment in the final screening round. Thirteen of 
the 35 articles did not meet the inclusion criteria; thus, 22 articles describing 19 different 
intervention studies were included in this review. 
 
Description of the studies  
We identified two overall “types” of interventions within the 19 studies. The first type (10 
studies) is a communicative session or intervention for residents carried out by a trained 
specialist or staff member at a “set-time session”. The aim of the second type (9 studies) was to 
teach care staff to apply communication techniques in daily care activities, the “daily-care” 
intervention. 
The ten set-time sessions or interventions included a walking program combined with 
conversation20-22, group validation therapy23,24, life review programs25,26, cognitive stimulation 
therapy27,28, and activity therapy.29 Table 1 shows the study characteristics of the set-time 
intervention studies. The number of participating residents in each study ranged from 30 to 201, 
and the severity of the dementia ranged from moderate (mean study group Mini-mental State 
Examination (MMSE) score 18.6) to severe (mean study group MMSE score 6). The intervention 
period varied from 6 to 52 weeks. 
The nine daily-care intervention studies consisted of training programs aimed solely at teaching 
care staff communication techniques30-35 or multicomponent training or educational programs 
that also included communication techniques.36-40 Table 2 shows the study characteristics of the 
daily-care intervention studies. The numbers of residents varied from 22 to 194, and the numbers 
of staff members varied from 31 to 124. One study trained specially hired certified nurses to 
carry out the intervention.39 The mean study group MMSE score was less than 10 in four studies, 
indicating that the participants were in a severe stage of dementia.30,32,38,40 The other five studies 
included participants with moderate or mild, as well as severe, dementia. All daily-care 
intervention studies started with a training period for the care staff. 
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After this period, the intervention was implemented in daily care. Seven studies assessed 
outcome measures at several times after implementation, varying from 2 weeks to 
12months.30,32,33,36-40 Each of two studies had only one post intervention assessment of 
outcomes, which took place at four weeks31 and 18 months.34,35 
 
Methodological quality 
There were great differences in the methodological quality of the studies. None of the 19 studies 
fulfilled all nine quality items. Table 3 shows the results of the quality assessment and the total 
quality score for each study. The decision whether the criteria were fulfilled or not was based on 
the information provided in the article, and if this information was inadequate, the decision was 
labeled “unknown”. Overall, the quality of the daily care intervention studies seemed poorer 
(mean fulfilled criteria 3.7 ± 1.6) than the quality of the set-time studies (mean fulfilled criteria 
4.5 ± 2.1). 
 
Effects of the interventions on communication  
Five set-time studies, which also had the highest scores for total quality, used quantitative 
outcome measures for communication that could be compared.20,21,26,27,29 The data from these 
studies were pooled in a meta-analysis, and a total of 371 residents with dementia (193 in 
experimental groups and 178 in control groups) were included. The study by Cott et al. had two 
control groups21, and we combined data from both groups before we entered them in the meta-
analysis.18 Standardised mean differences (SMDs) were calculated, and we chose the random-
effects model because of the heterogeneity-of-treatment effects across studies (χ2 = 24.59, df = 
3, p = 0.0001, I2 = 84%). The estimated overall effect was not significant for the treatment groups 
(SMD = 0.53, 95% CI = –0.07– 1.14, p = 0.09; Figure 1). 
Among the set-time studies that were not included in the meta-analysis, a group life review 
intervention found a significant improvement in social interaction for the experimental group25, 
and a walk-and-talk intervention showed significant positive effects for the conversation only 
group.22 The other three set-time intervention studies did not show any significant effects on 
communication outcomes. 
It was not possible to pool data for communication outcome data for the daily care intervention 
studies because the only two studies that fulfilled the quality criterion for randomisation did not 
use communication outcomes that were suitable for a meta-analysis.32,40 
Four of the daily-care intervention studies included a multicomponent training and education 
program for care staff that had a communication component.36-40 Positive effects on 
communication were found in all of these studies. Effects on interactive behaviours, nurse–
patient cooperation style, and nursing assistants maintaining their communication skills were 
evident for professional carers. Effects on residents were found for positive affect and interactive 
behaviour. 
 
 
Table 1.  Characteristics and findings of set-time studies  
 
Author/Year Intervention and comparison Study 
design/ 
Length 
N Outcome measures  Significant between group 
effects
*
 
Friedman and 
Tappen, 1991 
T: Conversation during planned walking; 30 min 3 times/week   
C: Conversation only; 30 min 3 times/ week  
RCT 
10 weeks 
R: 30 
S: - 
Cm: CAS; COS  
NPS: - 
COS (p < 0.007) 
Politis et al., 2004 T: Individual, standardised, structured activity; 30 min  
    3 times/week  
C: One-on-one unstructured interactions; 30 min 3 times/week. 
RCT  
4 weeks 
R: 36 
S: - 
Cm: NPI apathy  
NPS: total NPI  
None 
Spector et al., 
2003 
T: CST, 14 group sessions; 45 min/session, twice a week 
C: Usual activities  
RCT 
7 weeks 
R: 201 
S: - 
Cm: HCS  
NPS: CAPE-BRS; RAID  
None 
Cott et al., 2002 T: Walk-and-talk intervention in resident pairs; 30 min  
    5 times/week 
C1: One-on-one conversation with RA; 30 min 5 times/week 
C2: Usual activities 
RCT 
16 weeks 
 
R: 86 
S: - 
Cm: FACS 
NPS: LPRS-SIB  
 
None  
 
Haight et al., 
2006 
T: Life review delivered by care assistants; approximately 8 h total  
C: Usual care 
RCT 
6 weeks 
R: 31 
S: 15 
Cm: COS 
NPS: MBP 
COS (p < 0.005) 
 
Toseland et al., 
1997 
T: Validation therapy group; 30 min 4 times/week 
C1: Social contact group, one activity each meeting; 30 min  
      4 times/ week 
C2: Usual care  
 
RCT 
52 weeks 
 
 
R: 88 
S: - 
Cm: MOSES  
NPS: CMAI-O; CMAI-N; 
GIPB 
 
CMAI-O 
verbal aggression (p < 0.01;  
C1 vs T+C2) 
CMAI-N verbal aggression 
(p < 0.01) physical aggression 
(p < 0.001) physical 
nonaggression (p < 0.01; C1+2 vs T) 
Orrel et al., 2005 
(also Spector et 
al., 2003) 
T: Participants in CST groups + maintenance CST sessions  
C1: Participants in CST groups + no maintenance CST sessions  
C2: No intervention  
CT 
16 weeks 
R: 35 
S: - 
Cm: HCS  
NPS: CAPE-BRS  
 
None 
Tappen et al., 
2002 
T: Combined walking and conversation; 30 min 3 times/week  
C1: One-on-one conversation; 30 min 3 times/week 
C2: Walk-only, self-paced, independent or assisted; 30 min  
     3 times/ week  
RCT 
16 weeks 
R: 55 
S: - 
Cm: Picture description test 
 
Mean number of information 
units (p < 0.043; C1 vs T+C2) 
Conciseness score (p < 0.010;  
C1 vs T+C2) 
Tabourne, 1995 T: Life review groups; twice a week 
C: Week 1 and week 12, participation in treatment group 
     Weeks 2-11, recreation activities similar to those used in  
     treatment group but without protocol or cueing for  
     reminiscence 
QE-CT 
12 weeks 
R: 40 
S: - 
Cm: Observation of behaviour 
during sessions; 
Sociograms: communication 
patterns; 
Changes in attendance and 
Decrease of disorientation  
(p < 0.001) 
Improvement in social interaction 
(p < 0.001) 
 Author/Year Intervention and comparison Study 
design/ 
Length 
N Outcome measures  Significant between group 
effects
*
 
 
 
participation during activities 
NPS: Checklist of general 
behaviour 
Tondi et al., 2007 T: Individual and group validation therapy 
C: Usual care  
CT 
4 months 
R: 60 
S: - 
Cm: NPI apathy  
NPS: total NPI  
No statistical tests used 
*
 Significant effects in favour of treatment group unless otherwise stated. 
C= Control group; CAPE- BRS = Clifton Assessment Procedures for the Elderly- Behaviour Rating Scale; CAS = Communication Assessment Scale for the Cognitively 
Impaired; Cm = Communication ; CMAI-N = Cohen Mansfield Agitation Inventory - Nursing staff-derived; CMAI-O = Cohen Mansfield Agitation Inventory - Observer-
derived; COS = Communication Observation Scale for the Cognitively Impaired; CST= Cognitive Stimulation Therapy; CT = Controlled trial; FACS = Functional Assessment 
of Communication Skills for Adults; social communication and communication of basic needs relative to the independence dimension; GIPB = Geriatric Indices of Positive 
Behaviour; HCS = Holden Communication Scale; LPRS-SIB = London Psychogeriatric Rating Scale - Socially irritating behaviour; MBP = Revised Memory and Behaviour 
Problem Checklist; MOSES = Multidimensional Observation Scale for Elderly Subjects; irritability and withdrawal scales; NPI = Neuropsychiatric Inventory; NPS = 
Neuropsychiatric symptoms; QE-CT = Quasi-experimental controlled trial; R = Residents; RA = research assistant; RAID = Rating Anxiety in Dementia; RCT = randomised 
controlled trial; S = care staff; T = treatment group 
 
 
Table 2.  Characteristics and findings of daily care studies 
 
Author / Year Intervention Study 
Design  
N Outcome measures  Significant between group 
effects 
Magai et al., 
2002 
T: Training professional carers in nonverbal sensitivity; 2 weeks,  
    10 times 1h 
C1: Behavioural placebo, sessions for professional carers about  
      cognitive and behavioural aspects of dementia; no specific 
      attention to patient affect 
C2: No treatment control group 
RCT 
 
  
R: 99 
S: 31 
Cm: Facial expressions of 
emotion during interview for 
positive and negative affect 
(R) 
NPS: CMAI (R) 
None 
van Weert 
et al., 2005, 
2006 
T: NAs were trained in snoezelen by professional trainer;  
    Training: 4 times 4-h in-service sessions and homework  
C: Usual care 
QE-CT 
 
6 NH’s 
12 wards 
 
Cm: Eye contact (R + S); 
Smiling (R + S);     
Affective touch (S); 
Positive and negative affective 
and instrumental verbal 
communication (R + S) 
 
 
R: NA-directed gaze (p < 0.01) 
Smiling (p < 0.05) 
Negative affective verbal 
behaviour (p < 0.05) 
S: R-directed gaze, affective 
 touch and smiling (p < 0.001) 
Positive instrumental and 
affective verbal behaviour 
(p < 0.001) 
Negative instrumental and 
affective verbal behaviour  
(p < 0.001) 
Beck et al., 
2002 
T1: ADL intervention respecting R cognitive and physical abilities 
     carried out by project NA; 45-60 min/day for 12 weeks  
T2: PSA-intervention involving 25 modules designed to meet 
      psychosocial needs through engagement in meaningful activity;  
      12 weeks, R eventually participated 30+ min  
T3: Both ADL and PSA interventions; 90+ min/day for 12 weeks  
C1: One-to-one interaction with project NA; 30 min/day for 12 weeks 
C2: Usual care 
CT 
 
 
R: 179 
S: - 
Cm: DBS; AARS;  
Observable displays of affect 
scale; Positive VAS for affect; 
Negative VAS for affect 
 
Positive affect (p < 0.001)  
(facial expressions, body 
posture/movements, 
contentment, interest) 
Burgio et al., 
2002 
T + C: 4 weeks of behaviour management training with knowledge 
          and performance-based assessments of skill acquisition  
T: Formal staff management after training phase including additional 
    training and feedback from supervisory care staff  
C: Usual supervisory system after completing training phase 
RCT R: 88 
S: 106 
Cm: Occurrences of residents 
and staff interaction 
behaviours; BMSC (S) 
NPS: CMAI (R)  
S: maintaining communication 
skills more effectively 6 months 
after training (p < 0.05) 
Finnema et 
al., 2005 
T: Emotion-oriented care applied by trained NAs; 9 months  
C: Usual care  
CT
**
 
 
14 NH’s 
16 wards  
Cm: Questionnaire social 
Relationships (R)   
None 
  
 
R: 194  
S: 124  
NPS: CMAI (R) 
          BOS-IP (R) 
Wells et al., 
2000 
T: Educational program for professional carers; 5 20–30 min sessions  
C: Usual care 
 
QE-CT R: 56  
S: 44  
Cm: MIBM (R) 
         IBM (S) 
NPS: PAS (R) 
          LPRS (R) 
R: MIBM (p < 0.046) (more 
positive and appropriate 
interactions) 
PAS (p < 0.019) 
NA: Interactive behaviours (p < 
0.005) (verbal relevance, 
personal-attending, relaxed, and 
social/flexible behaviours) 
McCallion et 
al., 1999 
T: NAs communication skills program; 5 45-min group  
    sessions and 4 individual conferences of 30 min each  
C: No intervention  
CT
***
 
 
 
R: 105 
S: 88 
 
Cm: MOSES (R) 
NPS: CMAI (R) 
 
CMAI physical nonaggressive 
behaviour (p < 0.001) 
CMAI verbal aggressive 
behaviour (p < 0.001) 
Edberg et al., 
1996; 2001 
T: Implementation of supervised  individualised planned care  
C: Usual care  
 
QE-CT R: 22 
S: 39 
 
Cm: Nurse–patient 
cooperation style from 
morning care observation  
NPS: DBAS (R); MDDAS (R) 
Nurse–patient cooperation style  
(p < 0.001) 
 
Dijkstra et al., 
2002 
T: Package of communication enhancing strategies, including  
    memory books and a communication intervention for NAs  
C: Not mentioned 
CT R: 66 
S: 40 
 
Cm: Discourse characteristics 
from transcripts of conversa-  
tions between R and NA 
Discourse characteristics  
R: (p < 0.05) (information units, 
indefinite and unique words, 
repetitions) 
S: (p < 0.02) (more facilitators, 
encouragement, cues) 
*
 Significant effects in favour of treatment group unless otherwise stated; 
**
 Multi-sited, matched groups; 
***
Randomised by nursing home unit  
AARS = Apparent affect rating scale; ADL = Activities of daily living; BMSC: Behaviour Management Skills Checklist; BOS-IP = Behaviour Observational Scale for 
Intramural Psychogeriatrics; C = Control group; Cm = Communication  CMAI = Cohen Mansfield Agitation Index; CT = Controlled trial; DBAS = Demanding Behaviour 
Assessment Scale; DBS = Disruptive behaviour scale; IBM = Interaction Behaviour Measure; LPRS = London Psychogeriatric Rating Scale; MDDAS = Multi-Dimensional 
Dementia Assessment Scale two subscales used: behaviour and psychiatric symptoms; MIBM = Modified Interaction Behaviour Measure; MOSES = Multidimensional 
Observation Scale for Elderly Subjects; NA: Nursing assistant; NH = Nursing home; NPS = Neuropsychiatric symptoms; PAS = Pittsburgh Agitation Scale; PSA = 
Psychosocial activity; QE-CT: Quasi-experimental controlled trial; R = Residents; RCT = Randomised controlled trial; S = Care staff; T = Treatment group; VAS = Visual 
Analogue Scale 
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Table 3.  Quality assessment and total score of included studies 
                     
 A B C D E F G H I Total 
Set-time studies 
Friedman and Tappen, 1991 + +  + +  u + +  +  + 8 
Politis et al., 2004 + + +  - + + + u + 7 
Spector et al., 2003 + + +   + u  - +  + u 6 
Cott et al., 2002 + +   +  -  -  -  - + + 5 
Haight et al., 2006 + u  -  u u + +  + + 5 
Toseland et al., 1997 + u   - u +  +  u u + 4 
Orrel et al., 2005  -  - +  - u + +  - u 3 
Tappen et al., 2002 + u + u u  - u  - + 3 
Tabourne, 1995  -   - + + u  -  - u  -  2 
Tondi et al., 2007  -  -  - + u  - u  - + 2 
Daily care studies 
van Weert et al., 2005;2006  -  - + + + +  - + + 6 
Magai et al., 2002 + u  - + + + + u + 6 
Beck et al., 2002  - u +  - +  -  - + + 4 
Burgio et al., 2002 + u + + u + u u u 4 
Finnema et al., 2005  -  - + +  -  -  - + + 4 
Wells et al., 2000  -  - +  - +  -  - u + 3 
McCallion et al., 1999  -  -  - u +  - u u + 2 
Dijkstra et al., 2002  - u  -  - u + + u u 2 
Edberg et al., 1996; 2001  -  -  - + u  - + u u 2 
Quality criteria: A = randomisation, B = allocation concealment, C = inclusion/exclusion criteria specified, D = 
similarity of groups at baseline, E = assessors blinded to outcome, F = characteristics of participants lost to follow-up 
described, G = intention-to-treat analysis, H = power calculated, I = outcome measures valid. 
 + = criterion fulfilled, - = criterion not fulfilled, u = unknown if criterion is fulfilled 
 
Five studies investigated the effects of communication skill training for care staff. One of these 
studies did not include a communication measurement.30 The studies that found positive 
significant effects were an intervention combining a package of communication-enhancing 
strategies and memory books for nursing assistants31 and an intervention integrating snoezelen 
in 24-hour dementia care.34,35 The first study found effects on discourse characteristics for 
residents and care staff. Snoezelen aims to communicate at a nonverbal level through the 
stimulation of the primary senses. Teaching care staff applying these techniques during morning 
care proved to be effective, even for residents with moderate-to-severe dementia. 
The study of Magai et al. showed no significant effect on communication outcomes after 12 
weeks.32 However, a sharp increase in positive affect was reported for the intervention group in 
the first six weeks after the training and the authors suggest that training programs should 
include refresher sessions in order to remain effective. 
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Effects of the interventions on neuropsychiatric symptoms 
Data for effects on neuropsychiatric symptoms in four set-time studies were pooled.23,26,27,29 Two 
of these studies had also been included in the meta-analysis for communication outcomes, and 
the total score for quality was 4 or more for all four studies. 
A total of 312 residents with dementia (171 in experimental groups and 141 in control groups) 
were included in the meta-analysis. We calculated the SMDs for this meta-analysis, and we used 
a fixed-effects model because the test for statistical heterogeneity was not significant (χ2 = 4.94, 
df = 3, p = 0.18, I2 = 39.2%). The result was that the estimated overall effect on neuropsychiatric 
symptoms was zero (SMD = 0.00, 95% CI = –0.23–0.22, p = 0.97; Figure 2). 
Among the studies unsuitable for meta-analysis, a group life review intervention found a 
significant decrease of disorientation for the experimental group25, and a combined group and- 
individual validation therapy intervention found a decrease of the mean neuropsychiatric 
inventory score in the treatment group and a slight increase in the control group, but no 
statistical test for significance was used.24 Two studies did not include a measurement for 
neuropsychiatric symptoms.20,22 
It was impossible to pool data for neuropsychiatric symptom outcomes within the subset of daily 
care intervention studies. The two studies that fulfilled the quality criterion for randomisation 
used the Cohen-Mansfield Agitation Inventory as an outcome measure, but neither reported 
separate results for this questionnaire.32,40 
The only two studies that found significant positive effects on neuropsychiatric symptoms were 
an abilities-focused program38, and a program of communication skills for nursing assistants.30 
The training of care staff led to positive effects on residents’ calm-functional behaviour, agitation 
behaviour, and physically nonaggressive behaviour assessed after three months, and verbally 
aggressive behaviour assessed after three and six months. Other daily care intervention studies 
did not find significant effects32,36,37,39,40 or did not include a scale for measuring effects on the 
neuropsychiatric symptoms of the residents.31,34,35 
 
  
Figure 1.     Forest plot, which shows no significant overall effect of set-time studies on communication outcomes. 
Each study is represented by a square () and a horizontal line, which correspond to the point estimate and the 95% confidence intervals (CIs) of the standardised mean 
difference (SMD). The solid vertical line corresponds to no effect of treatment (SMD 0). The area of the squares reflects the weight of the study in the meta-analysis. The 
diamond (♦) represents the combined SMD, calculated in a random effects model with its 95% CI. 
df = degrees of freedom; Mean = the mean change in communication outcome and the corresponding standard deviation (SD) for patients in the control and 
experimental groups, respectively; Total = number of patients included in analysis. 
 
 
 
Figure 2.     Forest plot, which shows no significant overall effect of set-time studies on neuropsychiatric outcomes. 
Each study is represented by a square () and a horizontal line, which correspond to the point estimate and the 95% confidence intervals (CIs) of the standardised mean 
difference (SMD). The solid vertical line corresponds to no effect of treatment (SMD 0). The area of the squares reflects the weight of the study in the meta-analysis. The 
diamond (♦) represents the combined SMD, calculated in a fixed effects model with its 95% CI.  
df = degrees of freedom; Mean = the mean change in communication outcome and the corresponding standard deviation (SD) for patients in the control and 
experimental groups, respectively; Total = number of patients included in analysis. 
Study or Subgroup 
Cott et al., 2002 
Friedman and Tappen, 1991 
Haight et al., 2006 
Politis et al., 2004 
Spector et al., 2003 
Total (95% CI) 
Heterogeneity: Tau² = 0.38; Chi² = 24.59, df = 4 (P < 0.0001); I² = 84% 
Test for overall effect: Z = 1.72 (P = 0.09) 
Mean 
-0.4 
0.2 
5.26 
-3.9 
3.2 
SD 
1.52 
6.12 
4.5 
4.46 
6.3 
Total 
44 
15 
15 
18 
86 
178 
Mean 
0.13 
-4.52 
-4.33 
-4.2 
-0.2 
SD 
1.58 
5.74 
4.91 
4.42 
6.1 
Total 
30 
15 
15 
18 
115 
193 
Weight 
22.0% 
18.3% 
16.3% 
19.5% 
23.9% 
100.0% 
IV, Random, 95% CI 
-0.34 [-0.81, 0.13] 
0.77 [0.03, 1.52] 
1.98 [1.09, 2.88] 
0.07 [-0.59, 0.72] 
0.55 [0.26, 0.83] 
0.53 [-0.07, 1.14] 
Control Experimental Std. Mean Difference Std. Mean Difference 
IV, Random, 95% CI 
-4 -2 0 2 4 
Favours control Favours experimental 
Study or Subgroup 
Haight et al., 2006 
Politis et al., 2004 
Spector et al., 2003 
Toseland et al., 1997 
Total (95% CI) 
Heterogeneity: Chi² = 4.94, df = 3 (P = 0.18); I² = 39% 
Test for overall effect: Z = 0.04 (P = 0.97) 
Mean 
4.3 
-11.4 
-0.7 
0.14 
SD 
26.33 
15.82 
5.5 
2.66 
Total 
15 
18 
86 
22 
 141 
Mean 
-8.31 
-6.1 
-0.2 
-0.55 
SD 
11.93 
11.17 
6.1 
2.57 
Total 
15 
18 
115 
23 
171 
Weight 
9.4% 
11.6% 
64.5% 
14.6% 
100.0% 
IV, Fixed, 95% CI 
0.60 [-0.13, 1.33] 
-0.38 [-1.04, 0.28] 
-0.09 [-0.36, 0.19] 
0.26 [-0.33, 0.85] 
-0.00 [-0.23, 0.22] 
Control Experimental Std. Mean Difference Std. Mean Difference 
IV, Fixed, 95% CI 
-4 -2 0 2 4 
Favours control Favours experimental 
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Discussion 
A total of 19 intervention studies fulfilled the inclusion criteria for this review and two overall 
types of interventions were identified: structured and communicative sessions at set-times, and 
communication techniques in activities of “daily care”. The latter include training programs for 
care staff. A meta-analysis of five set-time interventions (communication) and another meta-
analysis of four set-time interventions (neuropsychiatric outcomes) found no significant overall 
effects. Positive effects for communication outcomes are shown in individual studies when set-
time interventions are single-task sessions, such as life review or one-on-one conversation, and 
when care staff apply communication techniques in daily care activities. The effect of both types 
of communication interventions on the neuropsychiatric symptoms of people with dementia is 
divergent. 
The difference in effectiveness between single and multi-task interventions might be explained 
by people with dementia having difficulty performing dual tasks.41 Furthermore, exercise may not 
benefit the cognitive functioning of people with dementia when cardiovascular risk factors are 
present.42 Tappen and colleagues’ study reported that participants were afraid of falling and 
needed considerable assistance with ambulation, or stopped walking when they were asked a 
question.22 
The positive results for the life review interventions are consistent with findings of a review on 
the effectiveness of reminiscence therapy on dementia patients, which suggested some potential 
benefits such as improvements in cognition.43 People with dementia are still able to recall 
memories from past life events, with the more important life events often being remembered 
quite clearly, even in the severe stages of the disease.44 Reminiscence, or life reflection, is 
therefore a sensible and simple strategy for improving communication between residents and 
staff. 
Training programs for care staff to be used in daily care have positive effects on verbal and 
nonverbal communication outcomes among care staff as well as residents with dementia. It is 
known that factors increasing the effectiveness of an educational or training program for 
healthcare professionals are longer training periods, active participation during the training, and 
individual attention.45 We indeed found that effective programs used interactive courses36-38, a 
little self-study36-38 and individual attention via a supervisory system.40 The results of the study of 
Magai et al. add to this knowledge in showing that training programs should include refresher 
sessions to remain effective.32 
In spite of the effects on communication, the effects of both types of communicative 
interventions on neuropsychiatric symptoms were marginal. This is remarkable since 
communication difficulties are associated with neuropsychiatric symptoms.12 If so, one would 
expect positive effects on neuropsychiatric symptoms in the studies included in this review. In 
most studies either no effects on behaviour were found or no outcome measure for 
neuropsychiatric symptoms were included. Only four out of the 19 studies found positive effects 
for specific problematic behaviours in residents. Only one study found positive effects on both 
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communication and neuropsychiatric symptoms. This particular study used a quasi experimental 
design and only fulfilled three of the nine methodological quality criteria, so it was difficult to 
draw a conclusion.38 
The two daily care interventions that had the best methodological quality both studied the 
effects of nonverbal communication techniques on communication between residents and care 
staff.32,34,35 The snoezelen study showed positive effects for communication outcomes. 
Methodological weaknesses were common in most of the research projects and the 
methodological quality of the studies was generally poor. The quality of the set-time studies was 
better than the quality of the daily care interventions, but the variability was too great to draw 
overall conclusions. As for the results of the meta-analyses and conclusions of this review, the 
following should be kept in mind. First, given the kinds of intervention studies we reviewed, it 
was not possible to blind the residents, care staff, or therapists in the treatment groups. To get 
reliable and objective data, it is important to at least blind the outcome assessors.19 
Unfortunately, for seven set-time studies, it remains unclear whether this was done 
properly.20,22,24-28 
Second, both the quality criteria for random assignment and allocation concealment were 
fulfilled for only four set-time studies20,21,27,29 and none of the daily care intervention studies. 
Using the Cochrane criteria, only two of the daily care intervention studies used a truly random 
method to assign participants to study groups.18 Therefore, it was impossible to pool data for 
daily care intervention studies. 
Third, the reliability and validity of the outcome measures that were used for communication 
were questionable. The validation of outcome measures in some studies included in this review 
was not justified, or instruments were specially developed and evaluated for the 
study.25,27,28,31,36,37,40 
However, these reservations apart, we conclude that there are promising effective psychosocial 
interventions to be used in residential settings. Moreover, the lack of effect on the 
neuropsychiatric symptoms of residents with dementia is no reason to preclude improving 
communication in high level residential care facilities. Instead of measuring effects on 
neuropsychiatric problems, researchers might think about improvements that retain the positive 
behaviours of the people in care. Some papers in this review describe improvements in positive 
behaviours of affect and mood26,39, but our results for neuropsychiatric symptoms might not be 
significant because they included negative behaviours (e.g. agitation) that did not, and perhaps 
cannot, improve.32,33,40 
This review indicates that care staff can improve their communication with residents with 
dementia when strategies are embedded in daily care activities or interventions are single-task 
sessions at set times. Staff training should include time for personal feedback, interactive 
learning and refresher sessions. These results offer the possibility of improving the quality of 
care, but not directly of reducing neuropsychiatric symptoms. More research is needed to study 
the effect of communication interventions on neuropsychiatric symptoms. 
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Abstract 
Introduction: The effectiveness of psychosocial interventions in treating people with dementia 
and their carers is increasingly emphasised in the literature. Dementia guidelines should 
summarise the scientific evidence and best practice that is currently available, therefore, it 
should include recommendations for psychosocial interventions. The aims of our study were (1) 
to collate dementia guidelines from countries across Europe and to check whether they included 
sections about psychosocial interventions, and (2) to compare the methodological quality and the 
recommendations for specific psychosocial interventions in these guidelines. 
Methods: The European dementia guidelines were inventoried. The methodological quality of the 
guideline sections for psychosocial interventions was assessed with the (AGREE) Appraisal of 
Guidelines Research and Evaluation instrument. The recommendations for specific psychosocial 
interventions were extracted from each of these guidelines and compared. 
Results: Guidelines for psychosocial interventions were found in five of 12 countries. Guideline 
developers, methodological quality and appreciation of available evidence influenced the 
inclusion of psychosocial interventions in dementia guidelines from Germany, Italy, the 
Netherlands, Spain and the UK. The UK NICE SCIE guideline had the best methodological quality 
and included the most recommendations for psychosocial interventions. Physical activity and 
carer interventions were recommended the most across all guidelines. 
Conclusion: The inclusion of psychosocial interventions in dementia guidelines is limited across 
Europe. High-quality guidelines that include psychosocial interventions and are kept up to date 
with the emerging evidence are needed. Throughout Europe, special attention to the 
implementation of evidence-based psychosocial care is needed in the next few years. 
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Introduction 
The value of psychosocial interventions in treating people with dementia and their carers is 
increasingly emphasised in the literature. The goals of psychosocial interventions are to improve 
the quality of life and to maximise function in the context of existing deficits.1 Scientific evidence 
for the effectiveness of this type of intervention in dementia care is growing because such 
interventions have shown a positive impact on cognition, quality of life and family carers as well 
as suppressing neuropsychiatric symptoms and associated distress.2-5 Psychosocial interventions 
are not limited to specific types of dementia, and no serious side effects have been reported. 
Pharmacological treatments have shown some efficacy, but contrary to psychosocial 
interventions, antidementia drugs are not effective for all types of dementia and are not 
tolerated by all patients.6-8 Furthermore, the efficacy and safety of drug therapies for 
neuropsychiatric symptoms have been questioned over the last decade.9-11 Psychosocial 
interventions are recommended as a safe firstline treatment for neuropsychiatric symptoms and 
are efficacious at all stages of dementia.12,13 Psychosocial interventions for carers are effective in 
postponing and decreasing the odds of institutionalisation, but similar results for 
pharmacological treatments are lacking.5,14,15 
The use of scientific evidence in healthcare decision-making is not automatic, and gaps between 
evidence and decision-making are present at all healthcare levels.16 Guidelines are an important 
tool for implementing evidence in daily practice. Ideally, they should summarise the scientific 
evidence and best practice that is currently available.17,18 Guidelines for diagnosing and treating 
dementia have been developed and published in several European countries. Besides scientific 
evidence, factors such as the healthcare system and professional culture may influence the 
inclusion of psychosocial interventions in these guidelines.  
The organisation and financing of dementia care (particularly social support) is often fragmented 
and differs between and within European countries.19,20 Some countries organise dementia care 
nationally, but others depend on regional and local policies and financing.19,20 In the latter case, 
national dementia guidelines, if they exist at all, may include only general and nonspecific 
recommendations for psychosocial interventions to fit all regions. Or development of dementia 
guidelines may rely on local initiatives. Furthermore, medical specialists diagnose most cases of 
dementia, but they tend to focus their treatments on pharmacological interventions.21 Clinical 
guidelines developed by medical specialists might not include recommendations for psychosocial 
interventions. 
All Europeans with dementia and their carers should have access to safe care, that optimises 
their quality of life and increases their chances of staying at home as long as possible. Not 
including psychosocial interventions in dementia guidelines could have consequences for the 
quality of dementia care. 
Recently published European dementia guidelines should therefore include evidence and 
recommendations for psychosocial interventions that parallel the emerging evidence base. The 
aims of our study were (1) to collate dementia guidelines from European countries and check 
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whether they include sections about psychosocial interventions, and (2) to compare the 
methodological quality and recommendations for specific psychosocial interventions of these 
guidelines. 
 
Methods 
We used a pan-European, multiprofessional clinical research network, INTERDEM (Timely 
Detection and Intervention in Dementia; http://interdem.alzheimereurope.org/) to gather 
information about guidelines and consensus papers for psychosocial interventions in dementia in 
Europe between May and October 2006. INTERDEM members in the following countries were 
sent an email with a request to gather relevant national guidelines: UK, Spain, Netherlands, 
Belgium, France, Germany, Ireland, Italy, Portugal, Switzerland, Greece, Poland, Sweden, Austria, 
Denmark and Finland.  
We extracted the title and the names of the authors and intended users from each guideline and 
consensus paper that we received. We assessed the methodological quality of the guidelines that 
included at least one recommendation for a specific psychosocial intervention and that were 
published from 2000 onwards. We also extracted the recommendations for specific psychosocial 
interventions from each guideline and compared them. The guideline with the highest Appraisal 
of Guidelines Research and Evaluation (AGREE) scores was taken as a reference point. We 
compared recommendations treating carers and neuropsychiatric symptoms in more detail 
because of emerging evidence of the effectiveness of psychosocial interventions in both matters. 
To measure the methodological quality of a guideline, we used the AGREE instrument, which was 
internationally developed and tested for appraising clinical practice guidelines.22 This instrument 
assesses the quality of reporting and the guideline development. It provides an appraisal of the 
predicted validity of a guideline, i.e. the likelihood of a guideline achieving its intended outcome. 
It comprises 23 items that are unequally divided over six domains: 
(1)  Scope and purpose (3 items), which cover the overall aim of the guideline. 
(2)  Stakeholder involvement (4 items), which covers the extent to which the guideline 
represents the views of its intended users. 
(3)  Rigour of development (7 items), which covers the process used to gather and synthesise 
the evidence and the methods for formulating and updating the recommendations. 
(4)  Clarity and presentation (4 items), which cover the language and format of the guideline. 
(5)  Applicability (3 items), which covers the likely organisational barriers and the behavioural 
and cost implications of applying the guideline. 
(6)  Editorial independence (2 items), which covers the independence of the recommendations 
and acknowledgement of possible conflicts of interest of the guideline development group. 
 
Each item was rated on a four-point Likert scale ranging from 4 (strongly agree) to 1 (strongly 
disagree). 
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Guidelines for psychosocial interventions were rated independently by at least two clinicians, 
practitioners or researchers in dementia care who were native speakers or who could read the 
guideline in its original language. We calculated standardised scores for each guideline, and for 
each domain of AGREE. We added the item scores of all appraisers to calculate the standardised 
scores as: [(obtained score - minimum possible score)/(maximum possible score - minimum 
possible score)] x 100%. The maximum and minimum possible scores = the number of items x the 
number of appraisers, either x 4 (strongly agree) or x 1 (strongly disagree). The ratings were 
based solely on the sections about psychosocial interventions. The only other guideline sections 
considered during the rating were the more general parts about the development of the 
guideline. Therefore, the scores do not reflect the quality of a guideline as a whole. 
 
Results 
Information about published guidelines and dementia care consensus papers was received from 
12 of the 16 countries in the INTERDEM network and supplementary Alzheimer’s Society 
contacts. This information included 31 dementia guidelines and consensus papers from 8 
different countries that were published between 1998 and 2006. 
There were no recommendations for using psychosocial interventions in four countries (Finland, 
Belgium, Denmark and Sweden), although two guideline groups in Sweden had work in progress, 
which they expected to complete in 2009. In France, Switzerland and Ireland, consensus papers 
that included psychosocial interventions were published, but we found no recommendations for 
using psychosocial interventions in the dementia guidelines. The range of guidelines and 
consensus papers for dementia care and their content are described elsewhere.23 
Seven guidelines from five countries were included for the assessment of methodological quality. 
They comprised one Italian guideline for clinical specialists24, one Spanish guideline for health 
and social care practitioners25, one German guideline for formal carers in institutional care26, two 
UK guidelines for practitioners and service commissioners27 and healthcare professionals28, and 
two guidelines from the Netherlands for general practitioners29 and formal carers in institutional 
care.30,31 
Table 1 gives the AGREE scores for all seven guidelines. Table 2 shows a comparison of the 
psychosocial interventions included in the guidelines. Table 2 only shows the interventions that 
at least one of the seven guidelines recommended. Both tables present the guidelines in order of 
highest to lowest score for the AGREE domain for rigour of development, which covers the 
searching for and selecting evidence and formulating and updating the recommendations. 
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Table 1.  Appraisal of sections about psychosocial interventions in European dementia guidelines. Appraisal of 
Guidelines Research and Evaluation domain scores 
 
Domain Guidelines Mean domain score 
UK
a
 UK
b
 GE NL
c
 IT NL
d
 SP 
Scope and purposes 89 65 89 83 57 39 78 71 
Stakeholder involvement 88 32 71 83 36 50 46 58 
Rigour of development 90 79 79 52 45 43 38 61 
Clarity and presentation 88 56 67 63 42 67 71 65 
Applicability 89 46 28 22 6 17 17 32 
Editorial independence 100 72 58 50 33 42 8 52 
UK = United Kingdom; GE = Germany; NL = Netherlands; IT = Italy; SP = Spain;  
All numbers are percentages. For each guideline: the highest domain score is bolded; the lowest domain score is 
underlined  
a
National Institute for Clinical Excellence and Social Care Institute for Excellence 
b
Scottish Intercollegiate Guideline Network 
c
Netherlands Institute for Health Services Research 
 
d
Wind et al. 
 
Table 2.  Comparison of recommendations for psychosocial interventions in different European guidelines 
 
  Guidelines 
 UK
a
 UK
b
 GE NL
c
 IT NL
d
 SP 
Intervention Recommended (yes/no/NRD) 
Carer interventions Yes
e 
Yes
e 
- - Yes
e 
Yes Yes 
Physical activities Yes Yes Yes - Yes - Yes 
Reminiscence Yes NRD Yes
f 
- Yes
g
 - NRD 
Multisensory stimulation/snoezelen Yes Yes
h 
Yes Yes
i
 No - - 
Massage/touch Yes - Yes - - - - 
Behaviour management Yes
j 
Yes
e,k
 Yes
l
 - - - Yes 
Cognitive behavioural therapy Yes
m 
- - Yes
n
 - - - 
Recreational activities Yes
e 
Yes
e 
- - - - Yes 
Environmental design Yes Yes
e 
- - - - Yes 
Cognitive stimulation  Yes
e,o 
Yes
e 
- - - - NRD 
Music therapy Yes NRD - - Yes
g
 - NRD 
Aromatherapy Yes No - - Yes - - 
Animal assisted therapy Yes - - - - - - 
Reality orientation NRD
 
Yes
e,p 
- - Yes
e,o 
- NRD 
Memory training NRD - - - Yes
g
 - - 
Validation  NRD NRD Yes
q 
- No - - 
Emotion-oriented care NRD - - Yes - Yes - 
UK = United Kingdom; GE = Germany; NL = Netherlands; IT = Italy; SP = Spain;  
NRD = Mentioned but no recommendation done 
 
a
NICE/SCIE 
b
SIGN 
c
Netherlands institute for health services research  
d
Wind et al. 
e
Strongly advised 
f
Recollection of positive memories only 
g
Not benificial to all patients 
h
Only when tolerated by a patient  
 
i
In case of apathetic behaviour 
j
Tailored and individualised 
k
In case of depression 
l
Need–Driven Dementia-Compromised Behaviour Model 
m
Patients and carers 
n
Behaviour therapy-Pleasant events/problem solving   
o
Group therapy not individualised 
p
Individualised not group therapy 
q
Validating attitude by nursing staff 
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Quality of guidelines 
Overall, the scope and purposes domain scored highest on average of all the AGREE domains 
(mean score 71%, range 39–89%, Table 1). Thus, in general, the objectives, the clinical questions 
covered and the patients to whom the guideline is meant to apply were specifically described in 
most guidelines. In contrast, the applicability domain scored lowest overall (mean score 32%, 
range 6–89%). This means that the organisational changes and cost implications of applying the 
guideline recommendations were ignored or barely described in most guidelines. 
The rigour of development domain scored 61% (range 38–90%) on average. The items rated the 
highest in this domain were about using systematic methods for finding evidence and the criteria 
for selecting the evidence. The low score items were the two items outlining the guideline 
updating and the external review process before publication. 
The NICE SCIE guideline from the UK scored best in all domains for its coverage of psychosocial 
interventions; it had the best overall methodological quality in this context. The UK guidelines 
scored the highest for rigour of development. They used systematic methods to find and select 
evidence, explicitly linked recommendations to the supporting evidence, mentioned an external 
review process, and outlined an updating process for the guidelines. 
The German guideline scored as high as the SIGN guideline for rigour of development, but did not 
mention an updating process. It scored under 50% only for the applicability domain. 
The two Dutch guidelines scored below the mean domain score for rigour of development. Both 
explicitly linked recommendations to supporting evidence, but the guideline for general 
practitioners did not mention an updating process. The Dutch guidelines scores for the 
applicability domain were lower than their scores for the other AGREE domains. 
The Italian guideline clearly described the methods for finding and selecting evidence, and it 
linked recommendations the supporting evidence. However, it did not provide a procedure for 
updating the guideline. This guideline had the lowest overall domain score, namely, 6% for 
applicability. 
The Spanish guideline had the lowest score of all guidelines for rigour of development. It did 
describe how evidence was searched for and methods for formulating recommendations, but did 
not describe clearly how evidence was selected or set forth a procedure for updating the 
guideline. Across domains, this guideline had the lowest score for applicability and editorial 
independence. 
 
Comparison of recommended psychosocial interventions 
The psychosocial interventions that were most often mentioned across guidelines were physical 
activity, carer interventions, multisensory stimulation/snoezelen and reminiscence (Table 2). All 
guidelines that mentioned the first two interventions also recommended them. While guidelines 
mentioned light therapy, life review involving negative memories, psychomotor therapy and 
simulated presence, the guidelines either did not recommend them or advised against them. 
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Three guidelines advised not using light therapy.24,27,28 One guideline advised against life review 
involving negative memories.26 
The NICE SCIE guideline had the best methodological quality and included the most 
recommendations for psychosocial interventions. All psychosocial interventions recommended 
by the SIGN guideline were also recommended by the NICE SCIE guideline. The UK guidelines 
were the only guidelines that recommended cognitive stimulation. The NICE SCIE guideline, 
however, included reality orientation and cognitive stimulation as one and the same 
intervention, whereas the SIGN guideline recommended them as two separate interventions. 
Five of the six psychosocial interventions recommended by the Italian and German guidelines 
were also recommended by the NICE SCIE guideline. In addition, only the Italian guideline 
recommended memory training. On the basis of the same but one studies, the NICE SCIE 
guideline did not recommend memory training because of a lack of benefits beyond the 
particular tasks trained. The German guideline was the only guideline that recommended the use 
of validation. 
The Spanish guideline mentioned several psychosocial interventions, but formulated no 
recommendations for about half of them. The psychosocial interventions that the Spanish 
guideline recommended were also recommended by the NICE SCIE guideline. 
The two Dutch guidelines combined paid less attention to psychosocial interventions than each 
of the other five guidelines separately. The Dutch guidelines were the only ones that 
recommended emotion-oriented care and had the least in common with recommendations of 
the NICE SCIE guideline. 
Five guidelines recommended interventions for family carers of people with dementia (Table 2). 
The NICE SCIE and the Italian guideline based their recommendations on more than 20 studies, 
which were generally similar. The SIGN guideline referred to only three studies, while five of the 
11 references included in the Dutch guideline were Dutch publications.29 None of the guidelines 
were very specific about which carer interventions should be used, except the NICE SCIE 
guideline. It recommended that carers have a care plan and that interventions be tailored to 
specific needs. It also suggested different types of interventions (e.g. skills training, social support 
and psychoeducation). 
Six guidelines included recommendations for the use of psychosocial interventions to treat 
neuropsychiatric symptoms. Both the Dutch and German guidelines for formal carers in 
institutional care aimed exclusively at managing neuropsychiatric symptoms. 
The German, Spanish and NICE SCIE guidelines included general recommendations for the use of 
psychosocial interventions to treat neuropsychiatric symptoms. They summarised a range of 
interventions that might be effective because positive, though inconclusive, results were found 
for their use. In addition, the German and NICE SCIE guidelines included recommendations for 
assessing neuropsychiatric symptoms. 
The Dutch NIVEL guideline and the Italian guideline linked specific interventions to specific 
neuropsychiatric symptoms. The first one recommended snoezelen for apathy in the later stages 
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of dementia. The Italian guideline recommended aromatherapy for reducing the agitation and 
aggression of some patients. The SIGN guideline reviewed the same evidence base, but it 
concluded that aromatherapy could not be recommended for reducing specific neuropsychiatric 
symptoms. It also advised against multisensory stimulation for people with moderate to severe 
dementia. 
 
Discussion 
Our inventory of dementia guidelines showed that recommendations for psychosocial 
interventions are included in dementia guidelines in five of 12 European countries. We compared 
the sections on psychosocial interventions in seven guidelines from these countries and found a 
wide variety between guidelines in the methodological quality and inclusion of recommendations 
for psychosocial interventions. The NICE SCIE guideline from the UK had the best methodological 
quality overall, and it included the most recommendations on psychosocial interventions. 
Our study revealed important factors that were related to the inclusion of recommendations for 
psychosocial interventions in guidelines. These factors were the influence of guideline 
developers, the methodological quality of the guidelines and the appreciation of available 
evidence. The influence of guideline developers was clearly visible in one Dutch guideline that 
specifically stated that psychosocial interventions were not included because they involve 
nonmedical disciplines that were not present in the developing work group.32 In contrast, 
another Dutch guideline and a German guideline were developed for formal carers in 
institutional care and included psychosocial interventions only.26,30,31 The guidelines that had 
better methodological quality, and especially, higher scores for the rigour of development 
domain, included more recommendations for psychosocial interventions in general (Table 2). 
Evidence was not appreciated in the same way across the guidelines. In the case of specific 
psychosocial interventions, such as aromatherapy or multisensory stimulation, review of the 
same evidence base resulted in disagreement between guidelines about whether to recommend 
it. Scientific evidence shows that psychosocial interventions are effective in dementia care in 
general, though the evidence for specific psychosocial interventions is still mixed and 
limited.13,33,34 Inconclusiveness of the evidence base was also why, in some countries like 
Denmark and France, recommendations for psychosocial interventions were found in consensus 
papers only and not in dementia guidelines.23 
Including recommendations for psychosocial interventions in guidelines is one thing; the practical 
implementation is another. A dementia survey in six European countries has found that, at the 
time of diagnosis, physicians recommend this type of intervention far less often than 
pharmacological treatments.21 Furthermore, a survey in the UK found that poor access to non-
pharmacological interventions was a major limiting factor for their use in the treatment of 
neuropsychiatric symptoms.35 Guidelines should encourage the implementation of 
recommendations by addressing the organisational barriers and the cost implications for 
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applying them, but in our study, most guidelines had low scores for the AGREE applicability 
domain. 
Most Europeans with dementia are cared for at home, and they want to stay at home as long as 
possible.19 In southern European countries, family members taking care of their ill relatives is a 
cultural tradition.19 Dementia care services (like home care, respite care and long-term care 
facilities) are lacking or unevenly distributed in these countries.19,20 Dementia patients often 
receive informal care only and the carer’s burden in southern countries is the greatest in 
Europe.19,36 Considering this, one might expect that guidelines from southern European countries 
would give extensive attention to carer support. Although the Spanish and Italian guidelines that 
we studied recommended carer interventions, the recommendations were rather general, and 
applicability in practice was barely addressed. One reason for this could be that both guidelines 
were national initiatives, whereas dementia care is organised on a regional and local level with 
great variability in services found across both these countries.20,37 In contrast, the NICE SCIE and 
SIGN guidelines from the UK were national guidelines that did consider local implementation and 
gave directions for adaptation to the local situation. 
There were national guidelines in Germany and the Netherlands as well, but most were aimed at 
specific professional groups or specific dementia-related issues, such as the use of restraints.23 
Only a few recommendations for psychosocial interventions were included in the Dutch 
guidelines; this is probably due to poor methodological quality and focus on pharmacological 
interventions. Furthermore, guidelines for specific professional groups do not promote 
collaboration, although collaboration between professionals is known to improve the quality of 
dementia care in both primary care and the institutional setting.38,39 High-quality, 
multidisciplinary, dementia guidelines like those from the UK could improve collaboration 
between professionals and promote the inclusion of psychosocial interventions. They might help 
remedy the lack of multidisciplinary dementia guidelines that was identified across Europe 
earlier.40 
For the support of family carers and the management of neuropsychiatric symptoms, scientific 
evidence shows that psychosocial interventions are most effective when they are individualised 
and tailored to the specific needs of the patient and the carer.14,39,41,42 There are guideline 
recommendations that simply state that some psychosocial interventions might be effective for 
carers or the treatment of neuropsychiatric symptoms. Such recommendations do not enable 
healthcare professionals to provide tailored and individualised care. We did not find clear 
recommendations for care plans, the assessment of carers, or the assessment of neuropsychiatric 
symptoms except for those in the NICE SCIE guideline. The knowledge that interventions are 
more effective when they are tailored and individualised has emerged in recent years. Some of 
the guidelines had been published before such evidence was available. Guidelines should be 
updated periodically to keep them up to date with scientific evidence. We note that the 
description of an updating process was lacking in five of the guidelines reviewed here. However, 
an update of the Dutch guideline for general practitioners is expected in 2011. 
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The use of the INTERDEM network enabled us to study the dementia guidelines from many 
countries. Unfortunately, it was not feasible to gather information about dementia guidelines 
from all the European countries, and some limitations should be considered in the interpretation 
of the findings. Our methodology for finding dementia guidelines across countries makes it likely 
that all the national guidelines were identified, but we may have missed some regional and local 
guidelines. In addition, our study represents the methodological quality and the 
recommendations of guidelines that were available at the time of the survey only. Dementia 
guidelines were being developed in at least one country (Sweden), and more countries may have 
since published dementia guidelines that include psychosocial interventions. A final limitation is 
the fact that we used the AGREE instrument, not to assess methodological quality of a guideline 
as a whole, but only for sections about psychosocial interventions. The instrument is sensitive to 
quality differences in clinical guidelines, but it is not certain to what degree the instrument allows 
comparison when only specific guideline sections are assessed.22  
 
Conclusion 
The inclusion of psychosocial interventions in dementia guidelines across Europe is limited, 
despite the growing evidence base for their effectiveness in dementia care. 
Healthcare professionals and policy makers should ensure that high-quality dementia guidelines 
that include recommendations for psychosocial interventions become available in all European 
countries. Guideline developers should ensure that guidelines are kept up to date with the 
emerging evidence, and they should encourage the implementation of recommendations by 
addressing the organisational barriers and cost implications for application. Researchers should 
focus their studies not only on finding significant effects for specific psychosocial interventions, 
but also on the development and evaluation of strategies for implementing psychosocial 
interventions effectively in daily practice. 
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Abstract 
Introduction: The evidence for the effectiveness of psychosocial interventions in dementia care is 
growing but the implementation of available evidence is not automatic. Our objective was to 
develop valid quality indicators (QIs) for psychosocial dementia care that facilitate the 
implementation process in various countries and settings. 
Methods: A RAND-modified Delphi technique was used to develop a potential set of QIs. Two 
multidisciplinary, international expert panels were involved in achieving content and face validity. 
Consensus on the final set was reached after a conference meeting where a third panel of 
dementia experts discussed measurability and applicability of the potential set. A retrospective 
cohort study was conducted to study the feasibility of using the final set in day care centres, 
hospitals, and nursing homes in Spain and The Netherlands. 
Results: A total of 104 recommendations were selected from guidelines and systematic reviews 
and appraised for their contribution to improving the quality of dementia care by 49 dementia 
experts. Twenty-five experts attended the conference meeting and reached consensus on a set of 
12 QIs representing the key elements of effective psychosocial care, such as shared decision-
making and interventions tailored to needs and preferences. Data from 153 patient records 
showed that all but one QI subitem were applicable to all three settings in both countries. 
Conclusion: Our multidisciplinary and multinational strategy resulted in a set of unique QIs that 
aims exclusively at assessing the quality of psychosocial dementia care. Following 
implementation, these QIs will assist dementia care professionals to individualise and tailor 
psychosocial interventions. 
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Introduction 
Dementia is one of the leading causes of burden of disease in developed countries, and the 
number of dementia patients is expected to rise further in the coming decade.1 Treatments that 
cure or stop progression of dementia have not yet been found.2 Consequently, optimizing quality 
of life of both patient and carer is the most important treatment goal. 
Psychosocial interventions aim to improve quality of life and psychological and social functioning, 
and to maximise function in the context of existing deficits.3,4 The scientific evidence for the 
effectiveness of psychosocial interventions in dementia care is growing.5-7 Dementia guidelines of 
various countries consider this type of intervention to be the first choice of treatment for various 
symptoms of the disease.2,8-10 In other countries, however, the inclusion of evidence on 
psychosocial interventions in dementia guidelines seems limited.10 In addition, psychosocial 
interventions were found to be recommended far less often by physicians than pharmacological 
treatments at the time of diagnosis.11 
The use of psychosocial interventions in dementia care is not automatic and an additional tool in 
the form of quality indicators (QIs) is needed to further facilitate the implementation process. 
Quality indicators are measurable elements of practice performance focusing on the structures, 
processes, or outcomes of care.12 Indicator elements are explicitly defined and act as building 
blocks in the assessment of care.13,14 A set of QIs for psychosocial interventions in dementia care 
representing the key elements of effective psychosocial care would enable dementia care 
professionals to check and improve the quality of the psychosocial care they provide in daily 
practice. 
To our knowledge, sets of QIs that have been developed and published for dementia mainly focus 
on diagnostics, screening, and pharmacological interventions, but they include very few 
indicators for psychosocial interventions.15-18 Our objective was to develop valid QIs for 
psychosocial interventions in dementia care that apply to various countries and settings. The set 
should help dementia care services and professionals implement evidence-based psychosocial 
care for dementia patients and their carers. 
 
Methods 
The QIs were developed as part of the European Collaboration on Dementia project (EuroCoDe, 
2006–2008), which was initiated and led by Alzheimer Europe.19 The working group that 
developed the QIs consisted of seven members of the Interdem network (Early Detection and 
Intervention in Dementia Group). The method the working group used to develop the QIs 
included the following four steps (Figure 1): 
1. Selecting recommendations from systematic reviews and guidelines. 
2. Expert panel rating of the recommendations. 
3. Constructing a set of potential QIs. 
4. Consensus meeting on the final set. 
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Step 1. Working group 
  
 
  
 
 
 
 
Step 2. Expert panel 
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Step 4. Interdem expert panel 
 
 
 
 
 
 
Figure 1.      Step-wise procedure to develop quality indicators for psychosocial care in dementia. 
Be=Belgium; De=Denmark; Fi=Finland; Fr=France; Ge=Germany; GP=General practitioner; Gr=Greece; It=Italy; 
Ne=Netherlands; No=Norway; OT=Occupational therapist; Po=Poland; Sl=Slovakia; Sp=Spain; Tu=Turkey; UK=United 
Kingdom.  
*General practitioner, neurologist, occupational therapist, working in a memory clinic, a nursing home, or for an 
Alzheimer society. 
 
Steps 1–3 were part of a RAND-modified Delphi procedure to achieve content and face validity of 
the QIs.13,14 This procedure combined expert opinion with evidence from literature and guideline 
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recommendations and included two expert panels, of which one was the working group itself. 
The aim of the fourth step was to discuss measurability and applicability of the potential QIs with 
dementia experts from various countries and to reach consensus on a final set of QIs. After 
consensus was reached, the feasibility was studied of using the final set of QIs in different 
countries and settings by extracting data from patient records. 
 
Selecting recommendations 
The first step of development consisted of the selection of recommendations for psychosocial 
interventions by the working group. Evidence-based recommendations were gathered from 
relevant systematic reviews in the literature and European dementia guidelines.19 The working 
group discussed all the recommendations that were obtained in this way in a face-to-face 
meeting. Recommendations were selected for the second step if they were based on scientific 
evidence and covered aspects of psychosocial care for people with dementia or their carers. 
 
Rating the recommendations 
The aim of the second step was to reach consensus among dementia experts on a key set of 
recommendations for psychosocial care. The selected recommendations were unequally divided 
into eight categories and presented to a European expert panel in two postal questionnaire 
rounds. The experts were professionals involved in dementia care and included researchers and 
medical and care professionals. 
Three strategies were used to include experts from as many countries as possible: (1) 
approaching experts at the Alzheimer Europe conference in Estoril, Portugal, in 2007, (2) emailing 
requests to Alzheimer centre coordinators in European countries, and (3) using the personal 
networks of working group members. 
Experts were asked to rate each recommendation twice on a 9-point Likert scale in the first 
questionnaire round. Recommendations were rated for usefulness in contributing to the 
improvement of quality of dementia care on a scale of 1 (not useful) to 9 (most useful), and the 
priority it should be given in the expert’s own country on a scale of 1 (lowest priority) to 9 
(highest priority). Experts were also asked to list their personal top five recommendations for 
each category, starting with the recommendation they found most useful for improving the 
quality of dementia care within the category. 
All recommendations included in the first round were also included in the second round. The 
same experts who took part in the first round were then asked to rate each recommendation for 
feasibility of implementation in their own countries within five years on a Likert scale of 1 (not 
feasible) to 9 (most feasible). 
 
Constructing a set of potential quality indicators 
The third step consisted of two face-to-face meetings. In the first meeting, the working group 
discussed the results of the first questionnaire round. A recommendation was selected for the 
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key set when it scored high on average for contributing to the improvement of quality of 
dementia care: a median score of 8 or 9. The experts also had to agree, meaning that at least 75% 
of the experts had to rate the recommendation within the highest tertile (a score of 7–9) to add it 
to the key set.20 
If these scores did not differentiate the recommendations well enough, the top five listings of 
each category were used. The overall ranking of the top five recommendations was calculated for 
each category. Each recommendation that an expert ranked first in its category was awarded five 
points, each recommendation ranked second was awarded four points, and so on. 
During the second meeting, the working group constructed a potential set of QIs on the basis of 
the set of key recommendations and the results of the second questionnaire round. Key 
recommendations that scored a median of 6 or less for feasibility of implementation were 
rejected as QIs unless the working group agreed that they covered a basic principle of 
psychosocial care in dementia and were, therefore, essential for improving quality. 
 
Consensus meeting on the final set  
The fourth and final step consisted of a consensus meeting, which was preceded by a pilot study 
using a convenience sample of dementia patients’ records. The aim of this pilot study was to test 
whether the potential QIs could be applied to dementia patients and their carers in various 
countries and settings, and whether data were available in patient records. 
Members of the Interdem network, including the working group members, were invited to a two-
day conference. Before the conference, the members were asked to gather QI data from patient 
records within the organisations in which they work. A form was constructed in English to enable 
the extraction of data. 
The results of this pilot study and the complexity of formulation of each QI were discussed at the 
conference. Afterward, the potential set of QIs was adjusted on the basis of the feedback from 
the conference participants and circulated one more time to reach consensus on the final set of 
QIs. 
 
Feasibility study 
A retrospective cohort study was conducted to assess the feasibility of using the final set in day 
care centres, hospitals, and nursing homes in Spain and The Netherlands. 
Managers at each setting selected dementia patients. The inclusion criteria were age 65 years or 
older, diagnosed with any type of dementia at least six months earlier, first visit to the hospital or 
day care centre at least six months ago, living in the nursing home for at least six months. 
Informed consent was obtained from each patient or their carer before data were collected. 
After the data were collected, they were entered in a database using the Statistical Package for 
the Social Sciences (SPSS 16.0 for Windows, SPSS Inc., Chicago, IL, USA). A QI was considered 
adhered to if it was fulfilled. In case of multiple items, all items had to be fulfilled. Quality 
indicators subitems were considered not applicable if irrelevant to the patient or the carer. 
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Results 
Selecting recommendations 
Seventeen systematic reviews that met the inclusion criteria were analysed.19 The inventory of 
dementia guidelines across Europe showed that eight dementia guidelines from five countries 
included one or more recommendations for psychosocial interventions.19 
The working group discussed all the recommendations collected from these sources and wrote a 
questionnaire for the second step. Complex recommendations that included multiple items or 
more than one statement were split up, so that there were 104 recommendations with a single 
statement or item to be rated (Figure 1). 
 
Rating the recommendations 
About 80 questionnaires were handed out to dementia experts attending the Alzheimer Europe 
Conference in Estoril, Portugal, in May 2007. The questionnaire was also emailed to the 
Alzheimer centre coordinators of 34 European countries in October 2007. Nineteen 
questionnaires were completed and returned. About 60 questionnaires were sent by regular mail 
to Interdem contacts in European countries. Thirty of the questionnaires were completed and 
returned. In total, we received 49 completed questionnaires. 
The 49 experts who participated in the first round were sent an email in May 2008 requesting 
them to fill in the second questionnaire, which was attached with the email. Fourteen experts 
returned the questionnaire. 
 
Constructing a set of potential quality indicators  
The working group discussed the results of the first questionnaire round in May 2008. These 
results showed that for usefulness 84 recommendations and for priority 59 recommendations 
scored a median of 8 or higher and received 75% or more of the ratings within the highest tertile. 
Because the statistical results did not differentiate the recommendations well enough, the overall 
top five rankings were calculated by category. All recommendations in the overall top five 
rankings also scored a median 8 or 9 and received 75% or more ratings within the highest tertile 
for usefulness. The working group therefore decided that the set of key recommendations would 
be based on the results of the top five listings. For the two categories with fewer than ten 
recommendations, only the top three recommendations were included. One category had only 
two recommendations, which the experts ranked as equally important and both were included. 
The working group discussed a total of 33 recommendations to compose the key set. They 
merged recommendations wherever possible, excluded the ones where the content overlapped 
with others, and rephrased them if necessary. This resulted in a set of 17 key recommendations. 
During the second meeting (October 2008), the working group discussed expert ratings for the 
feasibility of implementation. Six of the initial 33 recommendations scored a median of 6 or less, 
but none of the 17 key recommendations were excluded or changed because of these ratings. 
Finally, the working group constructed 15 QIs. They excluded four of the 17 key 
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recommendations during this phase because of difficulties in turning them into measurable 
elements, and they split two recommendations into two separate QIs each. 
 
Consensus meeting on the final set 
Twenty-five Interdem members from ten European countries attended the two-day conference 
“Quality indicators for psychosocial care in dementia” in September 2009. The conference 
participants of eight countries extracted data from patient records and provided feedback for the 
set of 15 QIs based on this exercise. The other conference participants who were not in a position 
to extract data provided feedback on the basis of their knowledge of dementia care services in 
their own countries. 
The feedback was used afterward to improve the feasibility of the set of QIs. Of the 15 potential 
QIs, three were not changed, seven were reformulated, four were merged and reformulated into 
two QIs, and one was excluded from the set because the conference participants agreed that it 
covered basic medical care rather than a psychosocial principle of dementia care. 
Finally, the conference participants were asked for their consent for these adjustments by email, 
and consensus was reached on a set of 12 QIs for psychosocial care in dementia. This final set 
consists of nine process indicators for people with dementia, two process indicators for informal 
carers, and one structure indicator for professional carers (Table 1). 
 
Table 1.  Quality indicators for psychosocial care in dementia 
 
Numerator  Denominator  
Diagnosis and assessment  
1. Number of people with dementia whose patient file records that diagnosis was 
discussed with the person with dementia 
Total number of people with 
dementia at service 
2. Number of people with dementia who are assessed* periodically
†
 for 
depression and/or anxiety 
Total number of people with 
dementia at service 
3. Number of people with dementia with registration in patient file and/or care 
plan of: 
 Life history  
 Social and family circumstances 
 Needs and preferences
‡
 
Total number of people with 
dementia at service 
Care plan and treatment 
4. Number of people with dementia whose patient file records that they are 
currently receiving psychosocial interventions, tailored to the person’s:  
 Needs and preferences
‡
 
 Cognitive and physical abilities 
Total number of people with 
dementia at service 
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Numerator  Denominator  
5. Number of people with dementia with a registered personalised care plan, 
shared between the person with dementia, informal carer and care professional, 
that is periodically
†
 updated. This means that: 
 At least two types of interventions were discussed with and offered to the 
person with dementia  
 The care plan is drawn up in agreement with person with dementia, informal 
carer and professional at the service 
 Response to initiated interventions is monitored less than one year ago   
Total number of people with 
dementia at service 
6. Number of people with dementia whose care plan includes: 
 ADL activities 
 Recreational and social activities 
 Structured day activities 
Total number of people with 
dementia at service 
7. Number of people with dementia who have an assigned professional who 
maintains regular contact with the patient and the main carer and ensures 
coordinated delivery of health and social care services 
Total number of people with 
dementia at service 
Behavioural problems 
8. Number of people with dementia who have behavioural problems with 
registration of a tailored care plan that:  
 Is based on an assessment*
§
 to establish factors likely to cause the behaviour 
 Includes registration of its frequency of review agreed on by the informal 
carer and staff involved  
Total number of people with 
dementia who have 
behavioural problems at service 
9. Number of people with dementia who have behavioural problems that are 
treated with a psychosocial intervention first before pharmacological treatment is 
started. 
Total number of people with 
dementia who have 
behavioural problems at service 
Informal carers 
10. Number of carers of people with dementia for whom it is registered that: 
 Respite or short-break care is offered to them 
 Other psychosocial interventions, tailored  to their needs and preferences are 
offered to them 
Total number of carers of 
people with dementia 
11. Number of carers of people with dementia who are periodically
†
 assessed
*
 for 
mood and coping 
Total number of carers of 
people with dementia 
Professional carers  
12. Number of staff at care service/facility that receive specific dementia-care 
training at least once a year 
Total number of staff at care 
service/facility 
*A structured and systematic approach to examine a certain condition. This means using validated 
scales/questionnaires or at least a standardised method that is used for all similar patients/persons within the 
organisation/service  
†At least once a year 
‡Important to person with dementia, related to the quality of life 
§ In case of behavioural problems the assessment ideally includes: physical health, depression, undetected pain or 
discomfort, side effects of medication, individual biography, including beliefs, spiritual and cultural identity, 
psychosocial factors, physical environmental factors, specific behavioural and functional analysis 
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Feasibility study 
We extracted data from 153 patient records to assess the feasibility of the 11 QIs for dementia 
patients and their informal carers. We obtained data for the QI for professional carers from care 
managers in The Netherlands and care staff in Spain. The subitem about carers being offered 
respite or short-break care (QI 10) was not applicable in the nursing home setting, so we 
excluded it when calculating adherence in this setting. 
The mean adherence (±standard deviation) to the 11 QIs for patients and informal carers was 
26.3% (±36.6%). Adherence per patient record ranged from 0% to 89%, and per setting from 11% 
(Spanish hospital) to 50% (Spanish nursing home). Table 2 shows the adherence to each QI by 
setting and country. 
The Spanish settings rated higher for assessing depression/anxiety and mood/coping (QIs 2 and 
11) than the Dutch settings, with the exception of mood/coping in the hospital setting. The 
hospitals in both countries showed 0% adherence for more than half of the QIs for patients. 
The indicator for assessing the depression/anxiety of dementia patients received the best 
adherence across all settings (68%). However, this adherence varied widely from 100% for the 
Spanish settings to 18%–33% for the Dutch settings. In general, adherence varied widely, 
although for each QI at least one of the settings rated 75% or more except QIs 5, 8, and 10. This 
indicates that it is possible to provide psychosocial care in line with these QIs. The low adherence 
to QIs 5 and 8 was mainly due to the subitems about offering/discussing at least two different 
interventions (QI 5) and the frequency of review (QI 8), of which no note was found in most 
patient records. 
 
Table 2.  Percentage adherence to the eleven quality indicators for patients with dementia and informal carers, 
based on documentation in medical records in Spanish and Dutch hospitals, day care centres, and 
nursing homes 
 
 
QIs Diagnosis and Assessment/ Care Plan and 
Treatment 
Hospital Day care NH 
Ne 
(n=27) 
% 
Sp 
(n=28) 
% 
Ne 
(n=18) 
% 
Sp 
(n=29) 
% 
Ne 
(n=22) 
% 
Sp 
(n=29) 
% 
  1. Diagnosis discussed  85 0 39 3 0 0 
  2. Depression/anxiety assessed < 12 months  33 100 28 100 18 100 
  3. Personal information in file  0 0 67 0 32 100 
  4. Tailored psychosocial interventions  7 4 83 14 50 97 
  5. Personalised care plan  0 0 0 0 0 0 
  6. Care plan includes activities 0 4 61 97 100 21 
  7. Assigned professional who has regular contact 26 0 61 93 91 97 
QIs Behavioural Problems (n = 11) (n = 14) (n = 4) (n = 15) (n = 16) (n = 21) 
  8. Tailored care plan  0 0 0 0 0 5 
  9. Psychosocial intervention first  0 0 50 0 75 0 
QIs Informal Carers (n = 27) (n = 28) (n = 18) (n = 29) (n = 22) (n = 29) 
10. Tailored interventions received/offered 26 0 22 0 0 0 
11. Mood and coping assessed < 12 months  19 4 50 93 0 100 
Ne = Netherlands; NH = nursing home; QI = quality indicator; Sp = Spain 
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Offering interventions to carers (QI 10) was documented in 28 cases (18%) – all but one from 
Dutch settings – but information about tailoring was lacking here. One-hundred-eight patients 
(71%) received psychosocial interventions, but patient records often lacked information about 
how these were tailored to the person (QI 4). Of the 81 dementia patients (53%) who showed 
behavioural problems, 14 (17%) had documentation of being treated with a psychosocial 
intervention first (QI 9). There were records of 58 patients (72%) receiving a pharmacological 
intervention for behavioural problems. 
In both countries, staff needed to have basic psychogeriatric training specific to the setting to 
work there. Overall, staff members had received training in the preceding year, although ongoing 
staff training was not obligatory in all settings. 
 
Discussion 
We have developed a set of 12 content- and face-valid QIs that represent the key elements of 
effective psychosocial care in dementia. To our knowledge, this set is the first that aims 
exclusively at psychosocial interventions in dementia care. It is applicable to various countries 
and settings, with the exception of the subitem on respite and shortbreak care being offered to 
carers. This subitem is meant to be excluded when the set is used in the nursing home setting. 
The EuroCoDe project offered a timely and unique opportunity to reach consensus with a large 
number of dementia experts from different disciplines and countries about the very essence of 
evidence-based psychosocial care in dementia. The result is a set of generic QIs covering the 
minimal standard of psychosocial care. The QI content assists healthcare professionals to 
individualise and tailor psychosocial care, to empower the patient and carer, and to provide 
social inclusion and continuity of care. Empowerment of the patient and carer means enabling 
them to control certain situations, providing care options, and creating new meaning in their 
lives.21 The QIs reflect this by giving informed choices (QI 5), promoting and enhancing strengths 
and abilities (QI 4), and taking into account needs and preferences (QIs 3 and 10). Important 
dimensions of social inclusion are being accepted and recognised as an individual beyond the 
disease and being able to participate in social activities.22 Care professionals being aware of the 
social and family circumstances (QI 3), discussing care options with both patient and carer (QI 5), 
and offering participation in recreational and social activities (QI 6) contribute to the social 
inclusion of the dementia patient and carer. As dementia is an ongoing disease process, the 
provision of care must also be ongoing. Continuity of care ensured by frequent review of the care 
plan (QI 8), monitoring response to initiated interventions (QI 5), and periodical assessment of 
depression and coping (QIs 2 and 11) is essential to quality psychosocial dementia care. 
All healthcare professionals involved in dementia care, regardless of their nationality or 
discipline, can use this set of QIs. International collaboration for developing QIs has considerable 
benefits, but transferring QIs from one country to another is not easy.23 Differences between 
developed countries exist in the availability and accessibility of dementia care services.24,25 Our 
feasibility study shows that the set applies to Spanish and Dutch dementia patients in hospitals, 
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nursing homes, and day care centres, and that there is considerable room for improving 
psychosocial dementia care in these settings. Nonetheless, it is likely feasible to use the QIs in 
similar settings in other developed countries as well. 
Although the EuroCoDe project focused on dementia care in European countries, the method for 
developing this set of QIs included evidence from the international literature. Furthermore, 
recommendations for psychosocial interventions in European dementia guidelines do not differ 
from those in non-European dementia guidelines.26,8-10 Therefore, using the QIs is not limited by 
country or continent. 
Despite these strengths, there are some limitations that should be taken into account. First, 
validity should be further tested, and especially the discriminatory capacity should be assessed, 
both across and within the various countries. Second, we did not measure interrater reliability in 
our study, but it should be assessed to allow accurate comparison of adherence scores between 
countries and settings when more than one person collects data. Third, although the set of QIs is, 
in theory, applicable to people with dementia and their carers living at home, this setting was not 
included in the feasibility study. For those who receive care from home care services, family 
physicians, or case managers, it is likely that case records documenting these activities exist. 
Future studies that access such records in order to check our proposed set of QIs are required. 
Fourth, the use of written records as a data source has some disadvantages, one of which is that 
most case records are incomplete. This leads to underestimation of the actual care delivered.27,28 
The use of additional data sources, such as interviews with care managers or carers, should be 
investigated in further studies. Finally, as was the case with the subitem related to respite and 
short-break care in the nursing home setting, other QIs may not be applicable to specific settings 
or disease stages. For instance, discussing the diagnosis is probably not relevant to people and 
carers in the final stages of dementia. Although discussing palliative care approaches might 
represent quality psychosocial care in these final stages, we have not included this subject in the 
current set. The content we outline is the first step toward establishing a broad set of QIs, which 
are not fixed but should evolve in line with the developing knowledge base. However, we suggest 
that this be underpinned with an equivalent systematic methodology before future refined QIs 
are disseminated widely. 
In an ideal world, everyone with dementia and his/her carer would have access to the best 
quality of care. In the real world, many obstacles hamper this access. The use of evidence-based 
guidelines and QIs in dementia care can lead to substantial improvements in the quality of 
care.29,30 The introduction of quality improvement cycles using the QIs for psychosocial care can 
generate important progress toward ideal dementia care. Professionals and services could use 
this set of QIs as a starting point to implement and improve evidence-based psychosocial care on 
a local level. 
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Abstract 
Introduction: Optimising the quality of life is an important goal in dementia care, for which 
psychosocial care is essential. We developed 12 quality indicators (QIs) to help implement 
evidence-based psychosocial dementia care in European countries. The purpose of this study was 
to explore barriers and facilitators in implementing the QIs and to compose an implementation 
strategy. 
Methods: Our qualitative study included a purposive sample of 27 dementia professionals from 
nine European countries and various disciplines including clinical psychology and general 
practice. These professionals took part in focus group interviews which were audiotaped and 
transcribed verbatim. We analysed the data inductively with ATLAS.ti. A model of barriers to and 
facilitators for change at six health-care levels became our framework for organising the data.  
Results: The QIs being a European initiative was both a barrier and a facilitator. Other 
implementation barriers were the variety in organisation of dementia care, QI ambiguity, and 
professionals’ lack of skills and motivation. The facilitators included the feasibility of using the QIs 
in practice, incentives, and QIs fitting in with national and regional policies. The participants 
proposed some implementation strategies.  
Conclusion: Our study is unique in exploring barriers and facilitators internationally. A barrier 
specific to this study context was the variety of dementia care organisation across countries. 
Implementation of the set must therefore be adapted to the local context and should consider 
barriers and facilitators in the specific political, economic, and organisational contexts, and the 
skills of local care professionals. Especially in countries where inclusion of psychosocial care in 
national dementia strategies or guidelines is limited, introducing the set of QIs could start the 
improvement of the quality of psychosocial dementia care.  
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Introduction 
The estimated number of dementia patients in the European Union is more than 6 million and 
the number of cases is expected to rise in the coming decade.1,2 No cure exists yet, so patients 
and their families have to cope with it and adapt their lives repeatedly to the further loss of 
cognitive function and the neuropsychiatric symptoms that accompany the disease. Optimising 
the quality of life of both patients and carers is one of the most important treatment goals in 
dementia care, and psychosocial care is essential to this process. 
Psychosocial dementia care aims at improving ‘psychological and social functioning, including 
well-being and cognition, interpersonal relationships and everyday functional abilities such as 
activities and daily living skills’ of both patients and carers.3 Scientific knowledge about the 
processes and conditions related to the successful delivery of psychosocial dementia care is 
accumulating.4-7 A dementia care innovation in a set of 12 evidence-based quality indicators (QIs) 
that represents the standard of psychosocial dementia care was developed as part of the 
European Collaboration on Dementia (EuroCoDe) project.8,9 The set explicitly defines measurable 
elements of psychosocial dementia care that act as building blocks in the assessment and 
improvement of this care.10  
Dementia strategies and guidelines are available in several European countries. Many of the 
national dementia strategies emphasise the importance of optimising the quality of life and 
include statements about the use of psychosocial care.11-15 Nevertheless, the inclusion of 
recommendations for psychosocial care in dementia guidelines for care professionals is limited 
across Europe.16 European physicians recommended this type of intervention far less often than 
pharmacological treatments at the time of diagnosis, and poor access is a major limiting factor 
for their use in the UK.17,18 The provision of psychosocial care for Europeans with dementia and 
their carers does not seem automatic and guaranteed. The set of QIs for psychosocial dementia 
care should facilitate implementation and improvement across countries. The implementation of 
innovations in health-care, however, is not a simple task, and various factors could facilitate or 
impede the implementation process.19-21 To increase the chances of improving the quality of 
psychosocial dementia care in Europe, the potential barriers and facilitators for implementing the 
set of QIs should be examined.  
Our aim was to explore the potential barriers and facilitators at six health-care levels for 
implementing the set of QIs across various European countries and to compose an 
implementation strategy based on these factors. The six health-care levels are the innovation 
itself, the individual professional, the patient, the social context, the organisational context, and 
the economic and political context.20 
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Methods  
The innovation 
The innovation consists of a set of 12 evidence-based QIs for psychosocial dementia care.8,9 The 
set includes nine QIs for patients covering diagnosis and assessment, care planning and 
treatment, and behavioural problems; two QIs for informal carers covering mood, coping, and 
offering psychosocial interventions; and one QI for care professionals covering dementia care 
training (Table 1). 
 
Table 1.  Examples of quality indicators for psychosocial dementia care, i.e. the innovation
8 
 
Patients - diagnosis and assessment 
Number of patients with registration in patient file and/or care plan of: 
 Life history  
 Social and family circumstances 
 Needs and preferences 
Patients - care planning and treatment 
Number of patients whose patient file records that they are currently receiving psychosocial interventions, tailored 
to the person’s:  
 Needs and preferences 
 Cognitive and physical abilities 
Patients - behavioral problems 
Number of patients who have behavioural problems that are treated with a psychosocial intervention first before 
pharmacological treatment is started. 
Informal carers – offering psychosocial interventions 
Number of carers of dementia patients for whom it is registered that: 
 Respite or short-break care is offered to them  
 Other psychosocial interventions, tailored  to their needs and preferences are offered to them 
 
Study design 
A qualitative design, using focus group interviews, was used to explore potential barriers and 
facilitators for the implementation of the set of QIs in various European countries. The focus 
groups met during a 2-day conference on QIs for psychosocial dementia care. The participants 
were a purposive sample of dementia care professionals and researchers who were also 
members of the Interdem network. This is a pan-European, multiprofessional network of 
professionals and researchers in dementia care who focus on psychosocial approaches.3 
Interdem members of 13 European countries, regardless of their disciplines, were invited to join 
the conference so that a wide variety of nationalities and disciplines were represented. There 
were no additional inclusion or exclusion criteria.   
In preparation for the focus group interviews, the participants received the set of QIs and were 
asked to use it to collect data from patient records in the organisations where they work. At the 
conference, each participant was assigned to one of the three focus groups. Each of these groups 
discussed barriers and facilitators in two sessions of 1.5 hours each. 
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Data collection 
A moderator led each focus group and used an interview guide to structure the discussion. The 
interview guide included barriers to and facilitators for implementing the QIs for patients and 
informal carers, professionals and organisations in dementia care, and national healthcare 
systems. Focus group meetings were audiotaped and transcribed verbatim. The meetings and 
transcriptions were both in English.  
 
Data analysis 
We analysed the focus group transcriptions inductively with ATLAS.ti version 6.2, using a 
framework approach.22 This approach consists of five interconnected stages: familiarisation, 
indexing (coding), charting, mapping, and interpretation. Two researchers (EV and MV) discussed 
the themes and the tentative framework that emerged during the familiarisation and indexing 
stages. We used a two-step approach for these stages.  
First, we used the interview guide as an initial coding framework and we coded the data as 
barriers or facilitators. We used open coding to further develop the framework. Second, we used 
a model for barriers and facilitators for change at six health-care levels (innovation, individual 
professional, patient, social context, organisational context, economic and political context) to 
organise the themes that had emerged during open coding.20 Quotes that related to informal 
carers of dementia patients were organised at the patient level, which was therefore renamed 
the patient and carer level. The tentative framework was adapted accordingly and all focus group 
transcriptions were indexed in line with the tentative framework.  
Then, a third researcher (AS) indexed half of the qualitative data using the tentative framework. 
EV and AS discussed differences and reached consensus about the final framework which was 
then applied to the whole dataset. If a quotation describing a barrier or facilitator related to 
more than one of the six health-care levels, it was assigned to the level that contributed the most 
to the barrier or facilitator.  
During the next stages of data analysis, quotes were charted, mapped, and interpreted on the 
basis of the themes included in the final framework.  
 
Results   
A total of 27 dementia experts from nine countries (Denmark, Norway, France, The Netherlands, 
Germany, Poland, Italy, Spain and the UK) representing the disciplines of clinical psychology, 
general practice, geriatric medicine, old age psychiatry, medical sociology, nursing and dementia 
research participated in the focus group interviews.  
Analysis of the focus group transcripts identified various barriers and facilitators for the 
implementation of the set of QIs. We found no barriers or facilitators in the social context, one of 
the six health-care levels. We found barriers, but no facilitators at the level of the patient and 
carer. The barriers and facilitators were associated with either the innovation itself or the 
provision of psychosocial care in dementia (Tables 2 and 3).   
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Besides barriers and facilitators, some participants proposed practical strategies to implement or 
disseminate the set of QIs (Table 4). We describe these results separately, after the description of 
the facilitators.  
 
Table 2.  Barriers, facilitators and quotes associated with the innovation itself per health-care level  
 
Innovation 
Barrier Unattractive  
 
The situation in Finland is that we are working on all sorts of indicators for 
health and social care……. people working in practices are getting a bit tired 
about receiving these new questionnaires about this and that.(group 1m) 
I think there’s a weakness by doing it across Europe in that sense because it can 
be dismissed, if it can be fit into a national plan, it’s gonna be helpful. (group 
1m) 
Feasibility  
 
I think it is a mistake to develop indicators for all situations…..I think the setting 
where people are is the most important ….. I don’t think we can have indicators 
that just go cross the border. (group 1m) 
Do we want to have quality indicators we measure at the patient? .... Because 
this makes us independent from the different structure of health services.... But 
I also don’t know how it’s really perfect to manage this kind of assessment or 
data collection. (group 1m)   
Formulation We do not discuss preferences, we have mostly one religion, and do not discuss 
sexuality with older people quickly.(group 3m) 
I am used to work with medical data which are considered more easily to 
review and I think it is much more difficult with social and psychological data. It 
is so easy to misunderstand. (group 2a) 
Facilitator Attractive 
 
 
I think that most dementia units in Spain not know anything about it [the 
QIs]….. I think that it is very important to establish a European consensus..... to 
get a care network, social or health network for dementia care and consider not 
only pharmacological treatment. (group 1m) 
Feasibility in 
practice 
 
When I was looking at the form of questionnaire and thinking about the people 
are busy and they try to find time to fill it in, I think that it is maybe quite 
helpful if there’s a list of explaining what psychosocial interventions are. So 
people can quickly see, do we have this? (group 1m) 
Organisational context 
Barrier Variety and 
change 
 
 
In Spain the other important problem is the different system of care in the 
country because the social service, health service has been transferred from the 
national government to the regional government and because of this we can 
find different models for treatment (group 1a) 
I know you have it in Holland, don’t you. That people can receive cash. And 
Germany, France is a little bit? So, I think it is increasingly European, which is 
going to reduce the number of things that you can count[assess with QIs] in 
that way. (group 2a) 
Use data from 
patient records 
You should not find the GP documentation in the nursing home and you should 
not find nursing home documentation in GP-files. So if you go with QIs and just 
say it wasn’t in the files, you should not expect it in the different 
documentation. (group 1o) 
I did mine in the memory clinic [gather QI data] it’s one that actually does offer 
interventions and I was surprised how vague. I knew people were doing it, but 
there was no record of it and no clarity. (group 1m) 
Facilitator Include in 
checklist 
I think it is better to have a kind of checklist for did you ask about preferences, 
did you ask about life history, rather than having checked this afterwards. See 
the checklist beforehand in the patient file. (group 2m) 
 Barriers and facilitators in implementing quality indicators 73 
Individual professional 
Barrier Attitude  
 
Perhaps one of the challenges is to say that nothing can be done unless 
providers and professionals wish it to be done. (group 2m)  
Everybody is just trying to make sure that they’re communicating the right 
information and they start to lose the carers preferences …. you find people 
getting involved going in with decisions based on what they’ve been told by 
other professionals and still not asking carers and people with dementia what 
they want and involving them in decisions. (group 2m) 
Facilitator Increased 
motivation 
If you get back a report and it says ok you have these QIs and the other 
institution has this. It makes people think about what they do different to other 
people. (group 1m) 
Patient and carer 
Barrier Few QIs for 
carers 
The number of indicators for the carer is rather small.  
Other participant: I agree with that. (group 2m)  
Facilitator None  
Economic and political context 
Barrier Confidentiality 
of patient notes  
One of the barriers I had initially to do this was actually to access patients notes 
without their consent. (group 2m)  
Facilitator Match with 
policies 
  
Actually in Germany by law the nursing homes are required to look for body 
mass index (BMI). The BMI is one quality indicator for nursing home care. So 
every patient will have it. (group 1m) 
Financial 
support and 
incentives 
 
They want to get money from the health insurances, or get a proof. We also 
have QIs for institutions now, every hospital and so are all checked if they meet 
certain requirements. And if this is something attractive and not something you 
must do or, which means more work to you. (group 3a) 
Influential 
organisations or 
people  
There is one organisation that is behind the QIs that are being used now in 
Holland and you need that organisation to being used and have a big impact. 
(group 2m) 
 
Table 3.  Barriers, facilitators and quotes associated with the provision of psychosocial care in dementia per 
health-care level 
 
Innovation 
Barrier None  
Facilitator Growing 
evidence base 
I think that new papers are supporting its promotion because every year we can 
read papers which are supporting psychosocial intervention.….it is the moment 
to promote psychosocial interventions as part of the health and social network 
with dementia patients. (group 1m) 
Organisational context 
Barrier Variety and 
change 
 
 
..if I think about the situation in our country [Finland] there is one problem and 
it is that we don’t have enough services …... Even if people are very skilled in 
providing psychosocial services and psychosocial support, there are not enough 
services. (group 1a) 
I have seen more people in less time and being less thorough and not staying 
involved with them as long as we used to. How I‘ve practiced 10 years ago 
would have been a lot easier to have met the QIs or said we are meeting them 
whereas now people just don’t have the time to be that thorough in their 
assessments and monitoring the people. (group 2a) 
Facilitator Care 
improvement 
efforts 
 
Who in the UK coordinates the social health practices, a manager or case-
manager? 
Other participant: Yeh, so often. The item [QI] about coordination would pick up 
on that and there are efforts to have linked case notes. Probably the care home 
have a record that includes both the health and social care. (group 1a) 
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Individual professional 
Barrier Lack of skills 
 
 
The care staff [in a specific care home] have no idea what a psychosocial 
intervention is, I mean they have absolutely no idea (group 2a) 
Physicians are not educated in all those interventions, they don’t know the 
contents of the interventions, so there is a lot of work to be done. (group 2m) 
Facilitator Feedback  
 
If I think about how to moderate people to fill-in these QIs. I think it is necessary 
that they get some immediate feedback after doing it. Some ideas about how to 
develop their care practices. (group 1m) 
Patient and carer 
Barrier Patient’s point 
of view  
I had a bit of a problem with the indicators with the word of offering because 
you’re always asking, looking if they understand it and what they want, so it’s 
not really our sight, it’s the sight of the patient. (group 2m)   
Refusal of care We offer a lot but many times it is refused. So, there is a kind of mismatch. We 
do want to, we have a lot of projects and creativity but the patients do not 
want that. (group 3a) 
Facilitator None  
Economic and political context 
Barrier No financial 
support 
 
I think it is in Finland also the problem that when the project is going everything 
is fine but when the financing is cut down then the good results also. They give 
money to those projects, but the implementation is not funded at all.(group 3a) 
Facilitator None  
 
Table 4.  Implementation strategies and quotes per health-care level 
 
Individual professional 
Include QIs in 
guidelines 
...guidelines differ from country to country, so I think the dissemination of evidence will be more 
useful more powerful in local, regional guidelines. (group 1m) 
Make QIs 
easy to use 
If you want to do quality indicators for benchmarking, you need some objective document, written 
records and you have to ask: “who is having written records?” and this are hospitals, GP’s, nursing 
homes and eventual ambulatory care systems. I  
would strongly recommend to structure the quality indicators concerned to these settings. (group 
1m) 
Include QIs in 
skills training 
In Italy, now in our region they have to give I think 20 hours I hear for training. For those who are 
working. …..and what I am thinking may be if we needed to introduce something about QIs or 
psychosocial intervention within this kind of training, to do something. Because they have to do it. 
(group 1a) 
Patient and carer 
Make QIs 
known to 
carers 
Everybody will have access to the Internet. And this national knowledge center [in Denmark] for 
dementia has made a homepage where you can go in and make e-learning.…. you could put QIs 
there as well. So, that the population would know or at least the relatives would know what shall I 
ask the system of. (group 3a) 
Economic and political context 
Use existing 
networks 
We have members of Interdem in all countries and I think that it is easy to translate and we could 
translate quality indicators as a consensus in different languages. (group 1m) 
 
Barriers 
Factors related to the innovation 
Unattractive. A set of QIs did not appeal to some of the participants because other sets of QIs 
had already been implemented in some countries. A new implementation might be perceived as 
extra work for professionals. The fact that the set was a European initiative rather than a national 
one made it less attractive to a UK participant.  
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Feasibility. One of the participants suggested that the ideal way of using the set would be to 
gather QI data from the perspective of the person with dementia by considering which care 
providers are involved in the provision of care, instead of taking on the perspective of care 
providers. However, this type of data collection was also thought to be less feasible to organise. 
Other participants did not think that the set could be applied to all patients regardless of the 
disease stage or setting.  
 
Formulation of the quality indicators. The participants thought that some QIs were stated too 
broadly. They also thought that, in general, QIs covering psychosocial care were more ambiguous 
and vague than QIs covering medical issues. In addition, one of the QIs stated that the person 
with dementia’s preferences should be registered. This QI included some examples of 
preferences that could be asked for (religion, sexuality and diet). These examples were thought 
not to be relevant in all cases and all countries. Some participants foresaw barriers regarding the 
translation of the set in their countries’ languages because of differences in terminology and 
specific words that were difficult to translate. 
  
Organisational context 
Variety and change in organisation of dementia care 
The wide variety in the organisation of dementia care between and within countries was seen as 
a barrier. Whereas QIs were relatively easy to implement in one region, this could be a challenge 
in another.  
In some countries, there was a shift towards governments enabling patients and carers to buy 
and organise their own care. This was also was seen as a barrier because it would be harder to 
gather QI data about these patients and carers.  
A participant from Germany mentioned that, compared to nursing home care, the organisation of 
home care is a grey area in Germany. Using the QIs to evaluate home care would therefore be 
difficult to organise nationally. In Finland, the capacity of dementia care services was thought to 
be insufficient to provide psychosocial care on a national level as the QIs require.  
The participants also remarked that the organisation of dementia care practice had changed 
during the last decade. Nowadays, there is more pressure to perform, and this means less time 
and fewer opportunities to use the set of QIs properly in practice. 
 
Using patient records to assess quality indicators 
The use of patient records for assessing the QIs was mentioned as a barrier because the data for 
all QIs could not be found in one place or setting and patient records were often incomplete.  
 
The individual professional 
Lack of skills. The participants in all three groups saw the skills and competences of professionals 
working in dementia care as an important barrier. Professionals in dementia care were not 
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thought to be automatically skilled to provide psychosocial care at the QIs level or to document 
the psychosocial care process in patient records. The focus group participants discussed the 
necessity of skills training and increasing awareness with regard to psychosocial care. 
 
Attitude. The attitude of professionals toward psychosocial interventions and the use of QIs  
were considered important for successful implementation but were also considered potential 
barriers. However, professionals using the QIs should not become too focused on meeting the 
quality criteria and documenting QI data no matter the source of the information. Some 
participants thought that professionals might forget to consult the dementia patient and carer.   
  
Patient and carer 
The dementia patient’s point of view. One of the focus groups discussed whether the dementia 
patient’s point of view was reflected well enough in the formulation of some QIs. If not, using the 
QIs as currently formulated would not guarantee the provision of quality psychosocial care. The 
participants discussed how to better formulate the QIs, but concluded that certain aspects of 
psychosocial care were not easy to describe.  
 
Dementia patients and carers might refuse care. One of the groups discussed whether all patients 
and carers would automatically accept the psychosocial interventions that professionals offered 
them. In these cases, a professional might not succeed in applying the QIs, despite all efforts.  
  
Too few quality indicators for carers. It was thought that the proportion of QIs for informal carers 
included in the set was rather small. The participants made suggestions for some additional QIs 
for informal carers. 
  
Economic and political context 
Specific policies at the national and regional levels and certain economic and financial issues 
were thought to have a negative influence on the implementation of the set of QIs. One barrier 
that was mentioned was the laws and policies regarding the confidentiality of patient files and 
medical notes. This would make it more difficult to access patient notes and to gather QI data in 
some countries. One group suggested that perhaps patient consent would be needed when QI 
results became public.   
The current negative economic situation was seen as a barrier because it meant less money to 
improve the quality of care on a large scale. Some participants also had the experience that 
governments provided financial means for short-term projects only, which meant that once a 
project was finished, so was the financial support. Subsequently, there was no financial support 
to implement successful interventions on a larger scale.  
 Barriers and facilitators in implementing quality indicators 77 
A participant from Spain mentioned that the government had set up special dementia units to 
regulate the expenditures for anti-dementia drugs. The result of this focus on cutting costs for 
pharmacological treatment was that these units gave little attention to psychosocial care.  
 
Facilitators 
Factors related to the innovation 
Attractive. Some participants saw the fact that the QIs were developed on a European level as a 
barrier for implementation. However, participants from Spain and Italy thought that this could 
actually be a facilitator for implementation in their countries.   
 
Feasibility in practice. Participants agreed that professionals should not have too many difficulties 
applying the QIs or gathering QI data. They thought that the success of implementing the QIs 
related to their user friendliness.  
 
Growing evidence base. The growing evidence base for psychosocial interventions in dementia 
care was mentioned as a facilitating factor for implementing the set of QIs.   
 
Organisational context 
Include quality indicators in checklist. Some participants suggested using the QIs for guidance 
during the care process would facilitate implementation. They suggested using the QIs as a 
checklist instead of checking adherence to the QIs retrospectively.  
 
Quality indicators and care improvement efforts. Participants from the UK mentioned that some 
of the QIs were in line with the current efforts to encourage collaboration between different care 
services and improve the coordination of care.   
 
The individual professional 
Professionals who are motivated to work with the QIs could facilitate the implementation 
process. The participants suggested that the added value of working with the QIs should be made 
clear to professionals and that they should receive feedback so that they could learn and develop 
their skills and practice. Incentives, like money or a quality certificate, were also mentioned as a 
way of motivating professionals to work with the QIs.  
 
Economic and political context 
Quality indicators match with policies. It was thought that implementation would be facilitated if 
the QIs matched current national and regional policies or were included in new laws or policies. 
The participants provided examples of the success of this strategy in their countries.  
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Financial support and incentives from governments or insurance companies were suggested as 
facilitating factors. The participants gave examples of such financial support and incentives that 
had influenced implementation of other care improvement initiatives. 
 
Influential organisations and people. Some of the participants mentioned that, in their countries, 
specific organisations, insurance companies, and people, some of whom already use QIs, have a 
lot of influence on the quality of care in general and dementia care in particular. If these 
influential organisations or people supported the set of QIs for psychosocial dementia care, 
implementation could be facilitated through them.  
 
Implementation strategies 
Participants came up with strategies to disseminate or implement the set of QIs in their 
countries or across Europe. These strategies were found at the health-care levels of the individual 
professional, patient and carer, and in economic and political context.  
 
The individual professional 
Include quality indicators in guidelines. Participants from Spain and Italy thought that including 
the QIs in guidelines aimed at professionals would be an effective strategy. In Spain, publishing 
the set of QIs in local journals would be the first step toward achieving this.  
 
Make quality indicators easy to use. The participants suggested different strategies for increasing 
the user friendliness of the QIs. Suggestions were to group the QIs according to the setting where 
the QI data would be available, to formulate the indicators as clearly as possible, and to include 
the QIs in a checklist in the patient file to remind professionals what they should do and ask 
when providing care. Participants from the UK suggested that it would help if the QIs were 
adapted to the computer systems that are currently used in the UK. 
 
Include quality indicators in skills training. Two participants from different groups suggested that 
including the QIs in obligatory training and education sessions for professionals could facilitate 
implementation of the set in their countries.  
 
Patient and carer 
Make quality indicators known. One suggestion for an implementation strategy from the patient 
and carers’ perspective was to make the set available for informal carers so that they could use it 
as a tool to evaluate their care situation. 
 
Economic and political context 
It was suggested that international networks like Interdem or Alzheimer Europe could be used to 
disseminate the set of QIs. The Interdem network could be used to translate the QIs to different 
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languages. It could also be used to gather and compare QI data from various countries. One 
participant suggested that Alzheimer Europe could help in disseminating the set of QIs by sending 
it to national and regional Alzheimer Society members.  
 
Discussion 
Barriers and facilitators for implementing a health-care innovation, i.e. a set of 12 QIs for 
psychosocial dementia care, in various European countries were associated with the innovation 
itself and the provision of psychosocial care in dementia (Tables 2 and 3). Moreover, these 
barriers and facilitators were related to five of the six health-care levels included in a model for 
change at different health-care levels.20 Among the barriers were the professionals’ lack of skills 
and motivation, the variety in organisation of dementia care between and within countries, and 
ambiguity of the QIs. Among the facilitators were the user friendliness of the QIs, feedback and 
incentives to motivate professionals, and QIs fitting in with national and regional policies. No 
factors related to the social context were mentioned as barriers or facilitators. Focus group 
participants suggested a few strategies for implementing the set of QIs, most of which were at 
the level of the individual professional, e.g. including the QIs in skills training and practice 
guidelines. 
Quality indicators are widely used as a tool to assess and improve health-care quality and 
performance, and factors related to its adoption have been investigated too in other studies.23-27 
Our study is unique in that it explores barriers and facilitators on an international level in various 
settings, whereas other studies focus on implementing QIs in specific settings within one country. 
This is probably why the barriers that we found in the organisational context (namely, the variety 
of dementia care organisation between countries) and political context (namely, laws protecting 
patient notes) have not been reported in earlier studies.  
The European context of the set of QIs was seen as both a barrier and a facilitator. Whereas a 
participant from the UK thought that a European initiative would be given less priority than 
national initiatives, participants from Spain and Italy thought it could stimulate change in 
dementia care in their countries. An explanation for this difference might be that in the UK 
national dementia guidelines and strategies, including psychosocial care, were published recently 
and the government is currently encouraging implementation.11,13,14,28-30 In contrast, national 
dementia guidelines or strategies are not yet available in other European countries such as Spain 
and Italy, or they do not include many recommendations for psychosocial dementia care.15,16,31 
To disseminate the set of QIs in the European countries, the use of existing international 
networks was suggested as an implementation strategy. In general, networks are useful in the 
dissemination of innovations, although their exact role in implementation and worth in improving 
patient care is not entirely clear.32,33 
Our finding that the perceptions and attitudes of professionals should be taken into account 
when implementing the QIs in practice is also reported in other studies. A professional’s intrinsic 
motivation and perceptions about ease of usage and the reliability of the data used for the QIs 
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are related to successful implementation.23,24,27,33 In addition, feedback based on QI data 
encourages professionals to improve care practice.24,26 Incentives could be useful in some 
contexts, but one study found them less important than professional’s intrinsic motivation, while 
only a proportion of professionals in another study were willing to accept incentives.23,24,26 If QIs 
are linked to incentives, these QIs should be formulated unambiguously, and the participants in 
our study doubted the clarity of the QIs. The ambiguity of psychosocial care QIs in relation to 
medication measures was a reason not to include psychosocial care QIs in an international set of 
QIs for benchmarking mental health-care.25 
Facilitators at the level of the political and economic context, such as endorsement by credible 
national organisations, and QIs fitting in with local and national policies were identified as factors 
that could facilitate implementation.23,27,33 Several participants shared the experience that 
governments often do not provide the financial means to implement psychosocial care 
successfully. This finding is not restricted to dementia care only; it is a barrier to disseminating 
evidence-based psychosocial care in oncology as well.34 
The social context was not a primary contributor to barriers and facilitators in our study.20 The 
reason for this is probably its international focus. The social context, e.g. opinion of colleagues, 
culture of the network, and leadership, can probably best be investigated on a meso- or micro-
level of dementia care. Barriers and facilitators related to the social context should therefore be 
identified on a local level as part of an implementation process.  
A limitation of our study is the inclusion of a purposive sample of dementia care professionals 
who were members of an international group that focuses on psychosocial dementia care. This 
means that the attitude of focus group participants was positive and they were relatively much 
more knowledgeable than other professionals about the provision of psychosocial dementia care 
and its current evidence base. Conducting focus groups with professionals who have less 
knowledge or even a negative attitude about psychosocial dementia care could reveal additional 
barriers and facilitators. Furthermore, our study did not identify many barriers and facilitators at 
the level of the patient and carer. Including patients and informal carers in focus group interviews 
could uncover barriers and facilitators at this health-care level. 
Another limitation is that focus group discussions took place in the English language even though 
this was not the first language of most participants. However, we do not think that it undermined 
the results of the study because most participants had met each other before at Interdem 
meetings. They were used to, and felt comfortable, expressing their opinions in one another’s 
company, which is an important condition for the success of focus group interviews.35 The 
international focus of our study made it essential that participants from different countries 
discussed barriers and facilitators with one another. Otherwise, important differences between 
countries, such as the variety in organisation of dementia care and the opinion about the 
European context of the QIs, would not have been revealed. 
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Conclusion 
Combining our findings with those of other studies, we conclude that it is not feasible to apply 
one strategy for successfully implementing the set of QIs in the various European countries. As 
with clinical guidelines, implementation needs to be adapted to the local context.36-39  
The organisation of dementia care varies widely between and within countries. National and 
regional governments, policies, and laws could facilitate, but also hinder, the implementation 
process. Factors relating to the organisational, political, and economic contexts should be taken 
into account in all countries, but need to be addressed locally. Local implementation efforts 
should include strategies to motivate care professionals to use the QIs and to provide 
opportunities to develop their skills and competences. Successful strategies depend on the local 
possibilities and structures. They could include making QIs easier to use for local dementia care 
practice, providing feedback based on QI data, and including the QIs in skills training and 
dementia guidelines.  
Except for pharmacological interventions, the European Union has only a limited role in 
improving the quality of care across Europe.40 The collaboration between care professionals from 
different European countries is therefore necessary to set quality standards and improve quality 
of health-care in other areas, as in the case of psychosocial dementia care. Networks, like 
Interdem and Alzheimer Europe, could play a central role in disseminating the set of QIs on a 
macro-level and raise awareness across countries. Especially in countries where its inclusion in 
dementia guidelines or strategies is limited, introducing the set of QIs could be the first step in 
raising awareness and improving the quality of psychosocial dementia care.  
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General discussion 
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In this chapter the development and implementation of the set of QIs and its importance for 
dementia research and practice are discussed. The set’s content, evidence base, implementation, 
and methodological issues are critically reviewed, and the set’s usefulness for research and 
society is illustrated. 
 
The quality indicators represent the standard of psychosocial dementia care  
Psychosocial aspects of care are often under-represented in sets of QIs because medication and 
other clinical measures are considered easier to assess.1,2 However, the stepwise procedure 
described in this thesis resulted in a set of 12 content-valid and face-valid European QIs for 
psychosocial dementia care (table). Our study shows that valid QIs for psychosocial care that are 
measurable in and applicable to various countries and settings can be developed and used to 
evaluate the quality of psychosocial dementia care in clinical practice.  
All but one quality indicator in the set are process indicators. The information obtained from 
process indicators provides care professionals direct feedback about the processes that they did 
or did not follow and need to improve.3 Indicators describing processes of care are therefore 
important for achieving quality improvement in health care.4,5 The processes described in our set 
of QIs provide dementia care professionals with feedback about the extent to which evidence-
based psychosocial dementia care is provided. This includes: 
 The importance of tailoring and personalising care to the preferences and needs of the person 
with dementia and the carer, which is reflected in the QIs by 
- Documenting needs and preferences (QI 3) 
- Taking them into account when offering psychosocial care (QIs 4 and 10). 
 Social inclusion, communication with the person with dementia, and preservation of their 
autonomy, which is reflected by  
- Discussing care options with both the patient and the carer and offering choices (QI 5)  
- Offering participation in recreational and social activities (QI 6) 
- Discussing the diagnosis with the person with dementia (QI 1). 
 The use of psychosocial interventions first for behavioural problems, which is reflected in the 
content of QIs 8 and 9.  
 
To our knowledge, this set of QIs is the first that aims exclusively at psychosocial dementia care. 
The set provides added value to the available sets of QIs that focus on other aspects of dementia 
management, such as pharmacological care, medical care, diagnostics, and the management of 
dementia in general practice and memory clinics.6-10 If dementia care professionals were to 
combine and apply these sets, they could improve the quality of dementia care in general. This 
could be a starting point for integrating medical and social dementia care on the local level. The 
fact that most of these sets of QIs were developed within the context of one country does not 
prevent them from being used in other countries as well. Transferring QIs from one country to 
another is feasible if they are adapted to the local context.11 
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Table. Quality indicators for psychosocial care in dementia 
 
Numerator  Denominator  
Diagnosis and assessment  
1. Number of people with dementia whose patient file records that 
diagnosis was discussed with the person with dementia 
Total number of people with 
dementia at service 
2. Number of people with dementia who are assessed* periodically† for 
depression and/or anxiety 
Total number of people with 
dementia at service 
3. Number of people with dementia with registration in patient file and/or 
care plan of: 
 Life history  
 Social and family circumstances 
 Needs and preferences‡ 
Total number of people with 
dementia at service 
Care plan and treatment 
4. Number of people with dementia whose patient file records that they 
are currently receiving psychosocial interventions, tailored to the 
person’s:  
 Needs and preferences‡ 
 Cognitive and physical abilities 
Total number of people with 
dementia at service 
5. Number of people with dementia with a registered personalised care 
plan, shared between the person with dementia, informal carer and care 
professional, that is periodically† updated. This means that: 
 At least two types of interventions were discussed with and offered to 
the person with dementia  
 The care plan is drawn up in agreement with person with dementia, 
informal carer and professional at the service 
 Response to initiated interventions is monitored less than one year ago   
Total number of people with 
dementia at service 
6. Number of people with dementia whose care plan includes: 
 ADL activities 
 Recreational and social activities 
 Structured day activities 
Total number of people with 
dementia at service 
7. Number of people with dementia who have an assigned professional 
who maintains regular contact with the patient and the main carer and 
ensures coordinated delivery of health and social care services 
Total number of people with 
dementia at service 
Behavioural problems 
8. Number of people with dementia who have behavioural problems with 
registration of a tailored care plan that:  
 Is based on an assessment*§ to establish factors likely to cause the 
behaviour 
 Includes registration of its frequency of review agreed on by the 
informal carer and staff involved  
Total number of people with 
dementia who have 
behavioural problems at 
service 
9. Number of people with dementia who have behavioural problems that 
are treated with a psychosocial intervention first before pharmacological 
treatment is started. 
Total number of people with 
dementia who have 
behavioural problems at 
service 
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Numerator  Denominator  
Informal carers 
10. Number of carers of people with dementia for whom it is registered 
that: 
 Respite or short-break care is offered to them 
 Other psychosocial interventions, tailored  to their needs and 
preferences are offered to them 
Total number of carers of 
people with dementia 
11. Number of carers of people with dementia who are periodically† 
assessed* for mood and coping 
Total number of carers of 
people with dementia 
Professional caregivers  
12. Number of staff at care service/facility that receive specific dementia-
care training at least once a year 
Total number of staff at care 
service/facility 
*A structured and systematic approach to examine a certain condition. This means using validated 
scales/questionnaires or at least a standardised method that is used for all similar patients/persons within the 
organisation/service 
†At least once a year 
‡Important to person with dementia, related to the quality of life 
§ In case of behavioural problems the assessment ideally includes: physical health, depression, undetected pain or 
discomfort, side effects of medication, individual biography, including beliefs, spiritual and cultural identity, 
psychosocial factors, physical environmental factors, specific behavioural and functional analysis 
 
The set of quality indicators is based on the best evidence available 
The European guideline inventory (Chapter 3), the review of systematic reviews12, and the 
systematic review of communication strategies (Chapter 2) contributed to identifying evidence-
based key elements for developing the set of QIs for psychosocial dementia care.  
Most evidence-based key elements for psychosocial dementia care were extracted from the 
recommendations in European dementia guidelines. The inventory of European dementia 
guidelines was therefore an essential step in developing the set of QIs. We used the AGREE 
instrument to assess the methodological quality of the guidelines. We found that the guidelines 
that had better methodological quality, and especially the ones with higher scores for the rigour 
of development domain included more recommendations for psychosocial dementia care. With 
respect to developing the set of QIs, the AGREE domain ‘Rigour of development’ is important 
because it relates to (1) the process used to gather and synthesise the evidence and (2) the 
methods for formulating the recommendations. The dementia guidelines included in our study 
had a higher average in this domain (61%, range 38–90%) than clinical practice guidelines in a 
wide variety of healthcare topics that Alonso-Coello and colleagues13 reviewed for quality (43%; 
95% CI 41.0 to 45.2). More importantly, we extracted most of the recommendations for 
psychosocial dementia care from the three guidelines that scored the highest for ‘rigour of 
development’ in our guideline inventory study.14-16 This means that the guideline 
recommendations had a scientifically sound evidence base for obtaining key elements for the set 
of QIs. 
Evidence-based key elements were extracted from systematic literature reviews. The findings of 
the systematic review of communication strategies extended the evidence base for the use of 
psychosocial interventions in institutional care. Although the interpretation of results was 
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complicated by the poor methodological quality of the individual studies, we were able to 
identify key elements that contributed to improving communication between care staff and 
people with dementia. These key elements are: (1) an intervention should have simple activities, 
each consisting of a single task, and these activities should be scheduled at set times or (2) an 
intervention should teach care staff to apply communication techniques in daily care activities. 
Other systematic reviews of psychosocial dementia care also distinguished effective from 
ineffective psychosocial interventions, despite the poor quality of the individual studies. An 
important key element identified from the best available evidence is: psychosocial interventions 
and care should be individualised and tailored to the specific situation, background, and needs of 
the person with dementia and their informal carer.17-20 
Quality indicators based on high-quality scientific evidence have more potential to improve the 
quality of health care, but scientific evidence for the effectiveness of psychosocial dementia care 
from randomised controlled trials (RCTs) only is scarce.4,5,21 However, the individually focused 
aims of psychosocial dementia care, such as the preservation of personhood, optimisation of 
well-being, and the quality of life of a person with dementia and their carer do not match the 
group-based information provided by RCTs.22 After all, what improves well-being and quality of 
life for one person might produce opposite effects for someone else. Providing evidence-based 
care based solely on the results of RCTs might result in the neglect of psychosocial aspects.22,23 
Therefore, evidence-based psychosocial dementia care should be based on the findings of all the 
relevant studies. The key elements of effective psychosocial dementia care that we extracted 
from dementia guidelines and systematic reviews were based on all the relevant studies of 
varying methodological quality. These key elements represent the best quality of scientific 
evidence currently available and are therefore essential for developing the set of QIs. 
 
Implementing evidence-based psychosocial dementia care 
The ability of clinical guidelines to improve the quality of health care depends not only on its 
methodological quality, but also on the extent to which health care professionals actually 
implement and use them.24 The European dementia guidelines that were included in the 
guideline inventory study (Chapter 3) gave little attention to the implementation of 
recommendations. Clinical practice guidelines in general give little attention to their applicability 
in practice. Alonso-Coello and colleagues’13 study found that the applicability domain had the 
lowest overall score of all the AGREE domains (22%; 95% CI 20.4 to 23.9). The dementia 
guidelines in our study also had the lowest average score in this domain (32%, range 6–89%). A 
reason for this might be that guideline developers consider guideline implementation as a 
separate activity, and they might feel that they lack expertise in this specific area.13 In our case, 
an additional reason may be that there is a paucity of research about effective strategies for 
implementing evidence-based dementia care.25 The set of QIs closes the implementation gap 
between guidelines and practice by facilitating the provision of evidence-based psychosocial 
dementia care. As part of the check phase of a quality improvement cycle (Plan-Do-Check-Act 
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cycle), QIs are an ideal instrument because QI scores show directly what actions need to be taken 
next.  
However, the set’s contribution to improving the quality of psychosocial dementia care also 
depends on the successful implementation of these QIs. The focus group interviews with 
dementia care professionals from various European countries and disciplines revealed that the 
European context of the set was perceived as both a positive factor and a negative one for 
implementing the set. Furthermore, implementation of the set of QIs in European countries must 
be adapted to the local context and the skills of local care professionals (Chapter 5).  
Implementing specific QIs might be relatively easy in one European region, but a challenge in 
another because of the great variability in dementia care organisation and available services 
between and within European countries.26,27 For instance, QI 7 states that each patient and their 
main carer should have an assigned professional who maintains regular contact. Depending on 
who is involved in dementia care and how dementia care is organised, this professional could be 
a case manager in one region, a general practitioner in another region, and another professional 
in a third region. Furthermore, respite or short-break care (QI 9) can only be offered to carers if 
these services are available, which is not automatically the case in all European countries.27,28 
Such services need to become available before the QI can be applied. Adapting the set of QIs to 
the local context as well as adapting the local context to the set of QIs may be necessary for 
successfully implementing the QIs.  
In addition, focus group participants thought that professionals in dementia care lacked skills and 
competences to provide psychosocial care at the QI level or to document psychosocial care in 
patient records. One way to overcome this barrier is to combine educating professionals with 
implementing the QIs. Two strategies that can be used to achieve this are providing feedback 
based on QI data and incorporating QIs in care processes as a reminder. The first strategy 
requires adherence to the QIs to be assessed periodically and feedback based on adherence 
scores to be given to the professionals.29,30 The second strategy entails reminders for the 
professionals about the correct processes of giving care according to the QIs. These processes 
must be incorporated in the routine data collection.3,31,32 One of these strategies should be 
included in the local implementation plan for the QIs. 
The European context of the set of QIs was perceived as a possible barrier for implementing the 
set across the UK. A UK focus group participant thought that a European set of QIs would be 
unattractive to dementia care professionals in the UK. In contrast, participants from Spain and 
Italy thought that the European context would facilitate implementation of the set in their 
countries. This difference in opinion was likely because recent UK dementia guidelines include 
psychosocial dementia care and government encourages implementation, whereas attention of 
Spanish and Italian guidelines, strategies, and government to psychosocial dementia care is 
limited, if present at all.33-39 Dementia care professionals in Spain and Italy might perceive a 
European set of QIs as imperative, while a European set of QIs probably has less priority than 
national initiatives for professionals in the UK. Nevertheless, adapting the QIs to the local context 
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in the UK might take less effort than adapting them to the local context in Italy and Spain. 
Considering the attention given to improving psychosocial dementia care in the UK, essential 
prerequisites for implementing the QIs, such as respite care services, are most probably already 
available. 
The EU-funded IMPACT (IMplementation of quality indicators in PAlliative Care sTudy) project, 
which is currently ongoing, aims to develop effective implementation strategies for using QIs to 
improve the organisation of palliative dementia care in Europe (http://www.interdem.org/ 
index.php/projects/current-projects). This project includes some of the QIs for improving 
psychosocial dementia care, and it will gather more knowledge about the factors that influence 
the successful implementation of QIs for dementia care in various European countries.   
 
Methodological considerations  
Few European dementia guidelines include recommendations for psychosocial dementia care, 
and recommendations from three European dementia guidelines, representing the UK and 
Germany, turned out to be the main sources for the evidence-based key elements for the set of 
QIs.14-16 This, however, does not mean that the final set is more applicable to the UK and 
Germany than to other European countries because the recommendations included in these 
guidelines are based on scientific evidence from the international literature and are not country-
specific. Furthermore, one or more dementia experts represented each of the 13 European 
countries in the RAND-modified Delphi procedure, and these experts reached a high level of 
consensus. All 17 key recommendations on which the final set of QIs is based received ratings of 
75% or more within the highest tertile for usefulness in contributing to the improvement of 
quality of dementia care. The set of QIs therefore represents the quality standard for 
psychosocial dementia care for various European countries. Nevertheless, we cannot be sure to 
what extent the final set of QIs represents the opinion of dementia care experts from eastern 
European countries, as only three of the 49 experts were representatives from this part of 
Europe. 
The process of developing the QIs resulted in a set with face and content validity that dementia 
care professionals can use as a tool to improve the quality of psychosocial dementia care at the 
local level. However, adherence to characteristics other than measurability and applicability must 
be assessed before the set can be used as a reliable tool to compare the quality of psychosocial 
dementia care on a large scale within or across countries. Such assessment is also necessary for 
governments’ or insurance companies’ benchmarks for accountability purposes. To allow 
accurate comparisons of QI adherence scores, the reliability of repeated measurement of the QIs 
should be established, as should the inter-rater reliability, in case more than one person collects 
data.4,40 Furthermore, to set benchmarks for the QIs, it is necessary to establish their 
discriminatory capacity. We must know how well QIs can (1) discriminate service providers’ 
quality of psychosocial dementia care and (2) detect changes in this quality.4,21,41 Investigating 
the set’s predictive validity, i.e. its capacity to predict quality-of-care outcomes, might determine 
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the relation between applying the set of QIs and important outcomes for people with dementia 
and their carers. These outcomes include quality of life, institutionalisation, and the burden of 
carers.4,40 Linking the care processes that the QIs describe directly to better outcomes for people 
with dementia and their carers would encourage the implementation of the set of QIs.3  
An additional consideration with regard to the reliability of the set of QIs is the use of patient 
records as a single source for obtaining QI data, as was done in the pilot studies in Spain and the 
Netherlands. Written records are often incomplete, which leads to underestimation of the actual 
care delivered.42,43 Incompleteness of the patient records in the Dutch and Spanish settings 
should be considered as a possible explanation for the low adherence scores for some of the QIs 
in this pilot study. The use of additional data sources, such as observations during care provision 
and interviews with care managers or carers, should be investigated in further studies to 
determine whether patient records as a single source suffice for assessing QIs. 
Our qualitative study (Chapter 5) reveals important barriers and facilitators for implementing the 
set of QIs, but its international focus was ineffective in uncovering barriers and facilitators related 
to the social context, the patient, and the carer. Before any local implementation begins, the 
local barriers and facilitators related to the social context, the patient, and the carer should be 
explored. The social context, i.e. the opinions of colleagues, culture of the network, collaboration, 
and leadership, can best be explored within a region among the organisations and/or 
professionals who must collaborate in implementing the QIs. In addition, to explore barriers and 
facilitators at the level of the patient and carer, the patients and carers themselves should be 
involved in the implementation. Their representatives, such as local Alzheimer’s societies, could 
substitute for patients and carers in this involvement.   
 
How can the quality indicators impact the quality of psychosocial dementia care? 
As long as there is no cure for any type of dementia, people with dementia and their carers 
should at least receive the best quality of care. The set of QIs for psychosocial dementia care can 
help to improve the quality of dementia care that is provided to Europeans with dementia and 
their carers. To summarise its strengths, the set of QIs: 
 Represents the key elements of effective psychosocial dementia care based on the best 
available scientific evidence from international literature, European dementia guidelines, and 
consensus among dementia care professionals and researchers from various European 
countries. 
 Is the first set of QIs that aims exclusively at psychosocial dementia care and enables 
assessment of the quality of psychosocial dementia care in European countries. 
 Is a practical instrument that assists dementia care professionals in implementing evidence-
based psychosocial dementia care. 
 
The set of QIs is a timely instrument because dementia has increasingly become a European 
health care priority and there is growing attention for the provision of effective psychosocial 
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dementia care. The Eurocode project, as part of which this thesis was produced, was one of the 
first European research projects to encourage collaboration between European dementia 
researchers.44 In continuation of this project, the EU Joint Programme - Neurodegenerative 
Disease Research (JPND), which focuses on Alzheimer’s disease in particular, was launched and a 
research strategy representing the common vision of 24 European countries was recently 
presented.45-47 Among the priorities for research are the further development of psychosocial 
interventions; promotion of social inclusion and carer involvement; and evaluation of equity of 
access to, and the effectiveness and cost-effectiveness of, pathways to treatment, care, and 
support. Furthermore, a growing number of national governments have recognised dementia as 
a health care priority and launched national programmes and strategies to facilitate 
improvements in both research and dementia care practice, including psychosocial dementia 
care.33,36-38,48 Within the context of this European dementia policy, the set of QIs for psychosocial 
dementia care offers opportunities for both dementia research and practice to impact the quality 
of psychosocial dementia care. 
 
Opportunities for research 
One of the research priorities that the JPND has set is the evaluation of equity of access to 
treatment, care, and support. To date, information about the equity and access to psychosocial 
dementia care in Europe is scarce, if available at all. In contrast, available European studies 
compare the presentation of dementia patients in memory clinics, resource use and costs of 
dementia, prevalence of dementia, place of death of people with dementia, the diagnostic 
process, and availability of anti-dementia drugs.26,28,49-54 Using the set of QIs for psychosocial 
dementia care to assess and compare access to psychosocial dementia care in various European 
countries would add currently missing knowledge about the equity of dementia care in Europe. 
The results might encourage governments of countries where the quality of psychosocial 
dementia care is poor to do something about it. 
In addition, the set of QIs facilitates the study of the effectiveness of providing evidence-based 
psychosocial dementia care on important outcomes for people with dementia and their carers in 
the real life situation. Better adherence to the processes that the set of QIs describes may be 
linked to a smaller chance of institutionalisation, less carer burden, or better quality of life. If so, 
such a link would underline the importance of psychosocial care as part of dementia care and 
management.  
  
Opportunities for practice 
The set of QIs can be a useful instrument for European dementia care professionals, whether or 
not their national governments have made dementia a health care priority and/or facilitate 
improvements in psychosocial care. In countries where governments do encourage 
improvements in dementia care, the set of QIs provides dementia care professionals with a 
ready-to-use instrument that makes their improvement efforts transparent to others. The set of 
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QIs can even be used to evaluate or rate dementia care providers, should a national system of 
benchmarking and/or reimbursement exist. In countries where governments do not encourage 
improvements, dementia care professionals can nonetheless introduce the set of QIs to start 
raising awareness of the importance of psychosocial dementia care. This set of QIs can also start 
improvements in the quality of psychosocial dementia care in their countries.   
The set of QIs can be useful to people with dementia and informal carers, as well as to dementia 
care professionals. Alzheimer Europe and local Alzheimer Societies can, if they wish, bring the set 
to the attention of people with dementia and their carers so that they can check the quality of 
care provided to them. They could then select the best services on the basis of QI performance. 
Being the care consumers, they could raise awareness among care professionals and demand 
improvements in the quality of psychosocial dementia care. 
The integration of medical and social dementia care services and multidisciplinary collaboration is 
increasingly being encouraged in European countries.33,34,48,55-57 As already mentioned, combining 
the set of QIs for psychosocial dementia care with other sets of QIs for dementia would largely 
cover the area of medical and social dementia care. If adapted to the local context, such a 
combination of sets offers an opportunity to introduce quality improvement cycles to guide the 
integration process on a local level.  
 
Conclusion 
Putting the available evidence into practice is not an automatic process in dementia care, and 
one of the many challenges is the volume of dementia research.25 In case of psychosocial 
dementia care, this is an important obstacle that has been overcome: the set of QIs presented in 
this thesis represents the key elements of evidence-based psychosocial dementia care, based on 
the best scientific knowledge currently available. The set offers both dementia researchers and 
care providers an opportunity to improve the quality of psychosocial dementia care, which would 
lead to improving the quality of dementia care in European countries.  
Although the set is ready for use on a local level, it is necessary to establish the inter-rater 
reliability, the discriminatory validity, and the predictive validity of the set before it can be used 
to compare the quality of psychosocial dementia care on a large scale within or across countries 
or for accountability purposes. These characteristics could be part of a future research project in 
which the set of QIs can be used to evaluate the quality of psychosocial dementia care in various 
European countries. 
The prevalence and burden of dementia will not only increase in Europe in the coming decades, 
but will affect countries all over the world.58,59 Alzheimer’s Disease International therefore calls 
for implementing the best quality of care and investing in research into dementia care 
worldwide.59 The set of QIs for psychosocial dementia care may help us face the major challenge 
of improving and spreading good-quality dementia care throughout Europe. The set is an 
attractive instrument for improving quality of psychosocial dementia care in countries other than 
European ones as well.  
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100 Summary 
Optimising the quality of life of both patients and their informal carers is one of the most 
important treatment goals in dementia care, and psychosocial care is essential to this process. 
Nevertheless, the implementation of evidence-based psychosocial dementia care in Europe is 
limited and needs to be encouraged. An important step in any effort to implement scientific 
evidence in practice and hence, improve the quality of health care, is the development of quality 
indicators (QIs). Quality indicators are explicitly defined and measurable elements of practice 
performance for which there is evidence, or at least consensus, that they can be used to assess 
improvement and change in the quality of care provided. The aim of this thesis was to develop 
and evaluate a set of quality indicators (QIs) to help implement evidence-based psychosocial 
dementia care in European countries.  
We used a stepwise process for developing and evaluating the set of QIs for psychosocial 
dementia care. The first step consisted of gathering evidence-based recommendations for 
specific psychosocial interventions and psychosocial care in general from the relevant systematic 
reviews in the literature and European dementia guidelines. All evidence-based 
recommendations that could be extracted from the systematic reviews that were selected for the 
review of systematic reviews, the systematic review of communication strategies (Chapter 2), 
and the dementia guidelines gathered in the guideline inventory study (Chapter 3) were used in 
developing the QIs (Chapter 4). In addition, we explored barriers and facilitators in implementing 
the set of QIs in various European countries (Chapter 5). The main findings from each of these 
steps are summarised here. 
 
Seventeen systematic reviews were selected, and evidence-based key elements of psychosocial 
dementia care were extracted. These key elements refer (1) to psychosocial care being 
individualised and multicomponent and (2) to care plans for carers including more intensive, 
long-term interventions. The review of systematic reviews revealed a paucity of reviews focusing 
specifically on the use of psychosocial interventions in institutional care. A systematic literature 
review, which Chapter 2 describes, has filled this gap. This literature review concerns the effects 
of psychosocial interventions on (1) the communication between residents with dementia and 
care staff in residential and nursing homes and (2) the neuropsychiatric symptoms of residents 
with dementia. Two overall ‘types’ of communicative, psychosocial interventions were identified. 
The first type (ten studies) is a communicative session or intervention for residents that a trained 
specialist or staff member carries out at a ‘set-time session’, such as a life review, one-on-one 
conversation, walk-and-talk intervention, or cognitive stimulation therapy. The second type of 
intervention (nine studies) is intended to teach care staff to apply communication techniques in 
daily-care activities, the ‘daily-care’ intervention. These interventions are either training 
programs aimed solely at teaching care staff communication techniques or multicomponent 
training programs that include communication techniques. The methodological quality of the 
included studies was generally poor.   
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A meta-analysis of five set-time intervention studies included two walking programs combined 
with conversation, a life review program, cognitive stimulation therapy, and activity therapy. 
Another meta-analysis of four set-time intervention studies included group validation therapy, a 
life review program, cognitive stimulation therapy, and activity therapy. Neither meta-analysis 
found any significant overall effect on communication outcomes or neuropsychiatric symptoms. 
Positive effects in communication outcomes appeared in individual studies when set-time 
interventions are single-task sessions, such as a life review or a one-on-one conversation, and 
when care staff use communication techniques in daily-care activities. The effects of the two 
types of interventions on neuropsychiatric symptoms were divergent. Overall, the review 
indicates that care staff can improve their communication with residents with dementia when 
strategies are embedded in daily-care activities or when interventions are single-task sessions at 
set times.  
 
Chapter 3 presents the results of the guideline inventory of evidence-based recommendations 
for psychosocial care in European dementia guidelines. We used the INTERDEM network, a pan-
European, multiprofessional, clinical research network, to collate dementia guidelines published 
from 2000 onwards in countries across Europe. The methodological quality of the guidelines was 
measured by means of the Appraisal of Guidelines Research and Evaluation (AGREE) instrument. 
Our study shows that the inclusion of psychosocial care in dementia guidelines is limited in 
Europe. Seven dementia guidelines from five of the 12 European countries had sections about 
psychosocial care that were suitable for inclusion in the study. Dementia guidelines from 
Germany, Italy, the Netherlands, Spain, and the UK included one or more recommendations for 
psychosocial care. Physical activity and carer interventions were the most recommended in all 
guidelines. 
The scope and purposes domain, i.e. description of the objectives, the clinical questions covered, 
and the patients to whom the guideline is meant to apply, had the highest average score of all 
the AGREE domains. The description of factors related to the implementation of a guideline 
scored lowest. Five of the seven guidelines lacked a description of an updating process. 
Important factors related to the inclusion of recommendations for psychosocial interventions in 
guidelines were the inﬂuence of guideline developers, the methodological quality of the 
guidelines, and the appreciation of the available evidence. 
The UK NICE SCIE guideline had the best overall methodological quality and included the most 
recommendations for specific psychosocial interventions. It recommended the use of carer 
interventions, cognitive stimulation therapy, recreational activities, physical activities, 
reminiscence, and other psychosocial interventions. 
Our study shows the need of high-quality dementia guidelines that include sections on 
psychosocial care and that are kept up to date with the emerging evidence. However, dementia 
guidelines alone cannot improve the quality of psychosocial dementia care. A tool in the form of 
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a set of QIs is needed to facilitate the implementation of evidence-based psychosocial dementia 
care in European countries. 
 
Chapter 4 describes the process of developing such a set of QIs. The evidence-based 
recommendations gathered from relevant systematic reviews in the literature and European 
dementia guidelines were included in a RAND-modified Delphi procedure. The procedure 
combined expert opinion with scientific evidence, and consisted of two postal surveys among 49 
European dementia professionals and researchers, face-to-face meetings of a small QI 
development group, and a final consensus meeting with 25 members of the INTERDEM network. 
This resulted in a final content-valid and face-valid set of 12 QIs consisting of nine process 
indicators for people with dementia, two process indicators for carers, and one structure 
indicator for professional caregivers. The QI content assists health care professionals in 
individualising and tailoring psychosocial care, empowering the patient and carer, and providing 
social inclusion and continuity of care.  
The measurability and applicability of the set of QIs was studied in practice: data were extracted 
from 153 patient records from nursing homes, hospitals, and day-care centres in Spain and the 
Netherlands. Adherence to the QIs ranged from 0% to 89% per patient record and 11% (Spanish 
hospital) to 50% (Spanish nursing home) per setting. At least one of the settings for each QI rated 
75% or more, with the exception of three QIs. This indicates that it is possible to provide 
psychosocial care in line with most of the QIs included in the final set.  
Although the validity of the set of QIs should be further tested on a larger scale, it is ready for 
European dementia care professionals and services to use it as a starting point to implement and 
improve evidence-based psychosocial care on a local level.  
 
Chapter 5 describes a qualitative study that explored the potential barriers and facilitators for 
implementing this innovative set of QIs in various European countries. An implementation 
strategy based on the barriers and facilitators was composed. Focus group interview sessions 
were used as a method to gather the qualitative data. The focus group participants formed a 
purposive sample of 27 dementia experts from nine countries (Denmark, Norway, France, the 
Netherlands, Germany, Poland, Italy, Spain, and the UK). These participants represented the 
disciplines of clinical psychology, general practice, geriatric medicine, old age psychiatry, medical 
sociology, nursing, and dementia research. All participants were members of the INTERDEM 
network. The focus group transcriptions were analysed inductively, in a framework approach. A 
model for barriers and facilitators for change at six levels of health care was used as a framework 
for organising the qualitative data. These levels were the innovation itself, the individual 
professional, the patient and the carer, the social context, the organisational context, and the 
economic and political context. 
The results showed that barriers and facilitators related to five of the six health care levels. The 
social context was not a primary contributor to barriers and facilitators, probably because of the 
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international focus of our study. The barriers included the professionals’ lack of skills and 
motivation, the variety in organisation of dementia care between and within countries, and the 
ambiguity of the QIs. The facilitators included the user friendliness of the QIs, the feedback and 
incentives to motivate professionals, and the QIs fitting in with national and regional policies. The 
European context of the set of QIs appeared as both a barrier and a facilitator. 
On the basis of the results, we conclude that it is not feasible to apply one single strategy for 
successfully implementing the set of QIs in the various European countries because the 
organisation of dementia care varies widely between and within countries. Further, national and 
regional governments, policies, and laws could facilitate, but could also hinder, the 
implementation. Implementation of the set of QIs therefore must be adapted to the local 
context. Local implementation efforts should also include strategies to motivate care 
professionals to use the QIs and to provide professionals with opportunities to develop their skills 
and competences. 
 
Chapter 6 discusses the stepwise process of developing and evaluating the set of QIs for 
psychosocial dementia care and its importance for dementia research and practice. The QIs 
represent the best quality of scientific evidence currently available for specific psychosocial 
interventions, and they capture the essence of psychosocial care in general. The set is ready for 
use on a local level. It is necessary to establish the inter-rater reliability, the discriminatory 
validity, and the predictive validity of the set before it can be used to compare the quality of 
psychosocial dementia care on a large scale within or across European countries or for 
accountability purposes. Within the current context of European dementia policy, the set of QIs 
offers opportunities for both dementia research and practice to impact the quality of 
psychosocial dementia care. 
 
 
 
Samenvatting 
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Het streven naar een zo goed mogelijke kwaliteit van leven voor zowel de persoon met dementie 
als diens mantelzorger is één van de belangrijkste behandeldoelen bij dementie. Psychosociale 
zorg is hierbij essentieel. De implementatie van evidence-based psychosociale dementiezorg is 
echter beperkt in Europa en moet worden gestimuleerd. Een belangrijke stap bij het 
implementeren van wetenschappelijk bewijs in de praktijk en daardoor het verbeteren van de 
kwaliteit van de gezondheidszorg is het ontwikkelen van kwaliteitsindicatoren. 
Kwaliteitsindicatoren zijn meetbare kernelementen van zorgverlening die expliciet zijn 
geformuleerd en waarvoor (wetenschappelijk) bewijs bestaat, of waarover op zijn minst 
consensus is, dat ze gebruikt kunnen worden om verbeteringen en veranderingen in de kwaliteit 
van de geleverde zorg vast te stellen. Het doel van dit proefschrift was het ontwikkelen en 
evalueren van een set van kwaliteitsindicatoren om de implementatie van evidence-based 
psychosociale dementiezorg in Europese landen te stimuleren. 
Voor het ontwikkelen en evalueren van de set van kwaliteitsindicatoren is een stapsgewijs proces 
gevolgd. De eerste stap bestond uit het verzamelen van evidence-based aanbevelingen voor 
specifieke psychosociale interventies en algemene psychosociale zorg uit de wetenschappelijke 
literatuur en Europese dementierichtlijnen. Alle aanbevelingen, welke werden verzameld via een 
review van systematische reviews, een systematische review over communicatiestrategieën 
(Hoofdstuk 2) en een inventarisatie van dementierichtlijnen in Europese landen (Hoofdstuk 3), 
werden gebruikt als basis voor de meetbare kernelementen voor de set van kwaliteitsindicatoren 
(Hoofdstuk 4). Aansluitend is onderzocht welke factoren de implementatie van de 
kwaliteitsindicatoren kunnen belemmeren of bevorderen in verschillende Europese landen 
(Hoofdstuk 5). De belangrijkste bevindingen uit elk van deze stappen zijn hier samengevat.  
 
Uit de zeventien systematische reviews die werden geselecteerd voor de review van 
systematische reviews konden de volgende evidence-based aanbevelingen voor specifieke 
psychosociale interventies en algemene psychosociale zorg worden verzameld: (1) psychosociale 
zorg moet worden geïndividualiseerd en bestaat uit meerdere, verschillende interventies (2) in 
zorgplannen voor mantelzorgers zijn psychosociale interventies opgenomen die intensief en 
langdurig zijn. De review van systematische reviews onthulde verder dat maar weinig reviews 
ingaan op het gebruik van psychosociale interventies in verpleeg- en verzorgingshuizen. Het 
systematische review beschreven in Hoofdstuk 2 gaat hier specifiek op in. In deze review van de 
wetenschappelijke literatuur worden de effecten onderzocht van psychosociale interventies op 
(1) de communicatie tussen verpleeg- en verzorghuisbewoners en verzorgenden en (2) de 
gedragsproblemen en andere neuropsychiatrische symptomen van verpleeg- en 
verzorgingshuisbewoners. Negentien studies werden geïncludeerd en twee typen interventies 
konden worden onderscheiden. Het eerste type, waartoe tien studies behoorden, is een 
communicatieve activiteit voor bewoners uitgevoerd door een getrainde professional of 
verzorgende die plaatsvindt op een vast moment, zoals het doornemen van een levensverhaal 
(life review), een gesprek voeren, tegelijkertijd lopen en praten of cognitieve stimulatie therapie.  
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Het tweede type, waartoe negen studies behoorden, heeft als doel om verzorgenden te leren 
communicatietechnieken toe te passen in de dagelijkse zorg aan bewoners. Deze interventies 
bestaan uit een trainingsprogramma specifiek gericht op het aanleren van communicatie-
technieken of een trainingsprogramma bestaande uit meerdere componenten waarvan 
communicatietechnieken er één is. De methodologie van de meeste van de negentien 
geïncludeerde studies was zwak.  
Een meta-analyse werd uitgevoerd van vijf studies met een communicatieve activiteit, bestaande 
uit twee interventies die wandelen combineerden met praten, een life review activiteit, 
cognitieve stimulatietherapie en een activiteitenprogramma. Een tweede meta-analyse werd 
uitgevoerd van vier studies met een communicatieve activiteit, bestaande uit een groepsvalidatie 
studie, een life review activiteit, cognitieve stimulatie therapie en een activiteitenprogramma. 
Geen van beide meta-analyses vond een significant effect voor uitkomsten op het gebied van 
communicatie of neuropsychiatrische symptomen. Individuele studies lieten een positief effect 
zien op de communicatie met bewoners wanneer een communicatieve activiteit bestond uit één 
taak of activiteit per sessie, zoals bij life review of het voeren van een gesprek met één andere 
persoon. Wanneer verzorgenden communicatietechnieken toepasten tijdens de dagelijkse zorg 
had dit ook een positief effect op de communicatie met bewoners. De effecten van beide typen 
interventies op neuropsychiatrische symptomen waren niet eenduidig. De conclusie van de 
review is dat verzorgenden de communicatie met verpleeg- en verzorgingshuisbewoners kunnen 
verbeteren wanneer communicatietechnieken worden toegepast tijdens de dagelijkse zorg of 
wanneer op vaste momenten communicatieve activiteiten worden aangeboden die bestaan uit 
één taak of activiteit per keer.  
 
Hoofdstuk 3 beschrijft de resultaten van de inventarisatie van Europese dementierichtlijnen. In 
deze studie is gebruikgemaakt van het INTERDEM netwerk, een multiprofessioneel, Europees 
onderzoeksnetwerk, om dementierichtlijnen te verzamelen die gepubliceerd waren in Europese 
landen vanaf 2000. De methodologische kwaliteit van de dementierichtlijnen werd beoordeeld 
met behulp van het AGREE-instrument. De studie liet zien dat de aandacht voor psychosociale 
zorg in Europese dementierichtlijnen beperkt is. Slechts zeven dementierichtlijnen uit vijf van de 
twaalf Europese landen waar dementierichtlijnen werden gevonden, bevatten secties over 
psychosociale zorg. Dementierichtlijnen uit Duitsland, Italië, Nederland, Spanje en het Verenigd 
Koninkrijk deden één of meerdere aanbevelingen voor psychosociale zorg. Fysieke activiteiten en 
interventies voor mantelzorgers werden het vaakst aanbevolen.  
Het onderwerp en doel van de richtlijn werd in de meeste dementierichtlijnen goed beschreven. 
Factoren gerelateerd aan de implementatie van de dementierichtlijnen werden niet of nauwelijks 
beschreven. In vijf van de zeven dementierichtlijnen ontbrak de vermelding van een procedure 
voor herziening. De inclusie van aanbevelingen voor psychosociale zorg in de dementierichtlijnen 
werd beïnvloed door richtlijnontwikkelaars, de methodologische kwaliteit van de richtlijn en de 
waardering voor het wetenschappelijke bewijs dat beschikbaar is.  
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De dementierichtlijn gepubliceerd door NICE-SCIE uit het Verenigd Koninkrijk scoorde het beste 
op methodologische kwaliteit en bevatte de meeste aanbevelingen voor specifieke psychosociale 
interventies. De richtlijn adviseerde onder andere het gebruik van psychosociale interventies 
voor mantelzorgers, cognitieve stimulatie therapie, recreationele activiteiten, fysieke activiteiten, 
en reminiscentie.  
De conclusie van deze studie is dat er een behoefte is aan dementierichtlijnen met een sterke 
methodologie waarin secties over psychosociale zorg zijn opgenomen. Daarbij is het belangrijk 
dat richtlijnen regelmatig worden herzien, zodat nieuwe wetenschappelijke inzichten kunnen 
worden toegevoegd. Dementierichtlijnen alleen zijn echter niet voldoende om de kwaliteit van 
psychosociale dementiezorg te verbeteren. Een set kwaliteitsindicatoren zou de implementatie 
van evidence-based psychosociale dementiezorg kunnen stimuleren in Europa.  
 
Hoofdstuk 4 beschrijft het proces voor het ontwikkelen van een set kwaliteitsindicatoren voor 
psychosociale dementiezorg. De evidence-based aanbevelingen die konden worden verzameld 
uit relevante systematische reviews en Europese dementierichtlijnen werden geïncludeerd in een 
RAND-modified Delphi procedure. In deze procedure werd de mening van experts gecombineerd 
met het beschikbare wetenschappelijk bewijs voor psychosociale dementiezorg. De procedure 
bestond uit twee schriftelijke vragenlijstronden onder 49 Europese dementie experts, face-to-
face bijeenkomsten van een kleinere werkgroep en een slotbijeenkomst om consensus te 
bereiken onder 25 Europese professionals uit de dementiezorg en onderzoek. Het resultaat was 
een inhouds- en indruksvalide set van twaalf kwaliteitsindicatoren voor psychosociale 
dementiezorg. De inhoud van deze set kwaliteitsindicatoren helpt zorgprofessionals bij het 
individualiseren en op maat leveren van psychosociale zorg aan mensen met dementie en hun 
mantelzorgers, het behouden van regie over eigen leven en het waarborgen van sociale inclusie 
en continuïteit van zorg.  
Gegevens uit 153 patiëntendossiers van verpleeghuizen, ziekenhuizen en dagopvangcentra in 
Spanje en Nederland werden verzameld om de meetbaarheid en toepasbaarheid van de set 
kwaliteitsindicatoren te onderzoeken in de praktijk. Adherentie aan de kwaliteitsindicatoren 
varieerde van 0% tot 89% per patiëntendossier en 11% (Spaans ziekenhuis) tot 50% (Spaans 
verpleeghuis) per setting. Deze praktijkstudie liet verder zien dat het goed mogelijk is om zorg te 
leveren zoals beschreven door de meeste van de kwaliteitsindicatoren in de set. Hoewel 
grootschaliger onderzoek nodig is naar de validiteit van de set kwaliteitsindicatoren kan het nu al 
gebruikt worden door Europese zorgprofessionals en instanties om op lokaal niveau evidence-
based psychosociale dementiezorg te implementeren en te verbeteren.  
 
Hoofdstuk 5 beschrijft een kwalitatieve studie om potentieel belemmerende en bevorderende 
factoren voor implementatie van de set kwaliteitsindicatoren in verschillende Europese landen te 
onderzoeken. Op basis van de gevonden belemmerende en bevorderende factoren werd een 
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voorstel gedaan voor een implementatiestrategie. De kwalitatieve data werden verzameld via 
focusgroep interviews. 
De deelnemers aan de focusgroep interviews waren 27 dementie experts, allen lid van het 
INTERDEM netwerk, uit negen Europese landen (Denemarken, Noorwegen, Frankrijk, Nederland, 
Duitsland, Polen, Italië, Spanje en het Verenigd Koninkrijk). Zij vertegenwoordigden de volgende 
disciplines: klinische psychologie, huisartspraktijk, geriatrie, psychiatrie, medische sociologie, 
verpleegkundigen en dementieonderzoek. De focusgroep interviews werden inductief 
geanalyseerd met behulp van een bestaand model met belemmerende en bevorderende 
factoren voor verandering op zes gezondheidszorgniveaus (de innovatie, de individuele 
professional, de patiënt en de mantelzorger, de sociale context, de organisatorische context en 
de economische en politieke context). Voor vijf van de zes niveaus werden belemmerende en 
bevorderende factoren gevonden. Voor de sociale context werden er geen gevonden, 
waarschijnlijk door de internationale opzet van de studie.  
Belemmerende factoren waren onder andere het gebrek aan vaardigheden en motivatie bij 
zorgprofessionals, de variatie in organisatie van dementiezorg binnen en tussen landen en 
dubbelzinnigheid van de kwaliteitsindicatoren. Als bevorderende factoren werden onder andere 
genoemd het gebruiksgemak van de kwaliteitsindicatoren, feedback en beloningen om 
professionals te motiveren en kwaliteitsindicatoren die passen in het regionale en nationale 
beleid. De Europese context van de set kwaliteitsindicatoren werd beschouwd als zowel een 
belemmerende als bevorderende factor voor de implementatie ervan.  
Op basis van de resultaten van deze studie concluderen we dat het niet mogelijk is om één 
implementatiestrategie te gebruiken om de set kwaliteitsindicatoren succesvol te implementeren 
in verschillende Europese landen omdat er een grote variatie is in de organisatie van de 
dementiezorg binnen en tussen landen. Daarbij kunnen nationale en regionale overheden, 
wetten en regionaal en nationaal beleid de implementatie bevorderen maar ook moeilijker 
maken. Implementatie moet daarom worden aangepast aan de lokale context. Daarbij zouden 
strategieën moeten worden gebruiken die professionals motiveren om de kwaliteitsindicatoren 
te gaan gebruiken en hun de kans geeft om vaardigheden en competenties te ontwikkelen. 
 
Hoofdstuk 6 bediscussieert het belang van de set kwaliteitsindicatoren voor dementieonderzoek 
en praktijk. De kwaliteitsindicatoren vertegenwoordigen de beste wetenschappelijke kennis 
beschikbaar op dit moment voor specifieke psychosociale interventies en ze bevatten de essentie 
van psychosociale zorg in het algemeen. De set is klaar voor gebruik op lokaal niveau. Voordat de 
set kan worden gebruikt voor het vergelijken van de kwaliteit van psychosociale dementiezorg op 
grote schaal binnen en tussen Europese landen of voor verantwoordingsdoeleinden moet eerst 
de interbeoordelaarsbetrouwbaarheid, het discriminerend vermogen en het voorspellend 
vermogen van de set worden bepaald. In de context van het huidige Europese dementiebeleid 
biedt de set kwaliteitsindicatoren kansen voor zowel dementieonderzoek als praktijk om invloed 
uit te oefenen op de kwaliteit van psychosociale dementiezorg. 
 
Samenvatting voor leken 
Dementie is een ongeneeslijke ziekte die de hersenfunctie aantast. Patiënten zijn steeds minder 
goed in staat om voor zichzelf te zorgen en dus steeds meer afhankelijk van anderen. Patiënten 
met dementie krijgen een groot deel van de nodige zorg en aandacht van hun naasten, 
zogenaamde mantelzorgers. Doktoren en andere zorgverleners streven bij de behandeling van 
dementie naar een zo goed mogelijke kwaliteit van leven, voor zowel de patiënt als de 
mantelzorgers. Hierbij is het essentieel dat de patiënt en mantelzorgers zorg krijgen die rekening 
houdt met de functionele beperkingen door de ziekte. Deze zorg let ook op het psychisch en 
sociaal welbevinden van patiënt en mantelzorgers en helpt hen om hun dagelijkse activiteiten zo 
goed mogelijk uit te voeren. Dit is de zogenaamde psychosociale zorg. Tot op heden is het 
onduidelijk in hoeverre psychosociale zorg deel uitmaakt van de behandeling van dementie-
patiënten en hun mantelzorgers in Europese landen. Ook is niet bekend of de psychosociale zorg 
die ze krijgen overeenkomt met de aanbevelingen uit wetenschappelijk onderzoek.  
Mijn proefschrift beschrijft het stapsgewijze proces voor het ontwikkelen en invoeren van een 
praktisch instrument, een set kwaliteitsindicatoren. Met deze kwaliteitsindicatoren kan men de 
kwaliteit van psychosociale zorg bij dementie meten in verschillende Europese landen. Het 
instrument is ontwikkeld in samenwerking met een groep Europese onderzoekers en 
zorgverleners. Tijdens de eerste stap in het ontwikkelingsproces heb ik uit Europese 
dementierichtlijnen voor doktoren en andere zorgverleners de aanbevelingen verzameld voor 
psychosociale zorg (Hoofdstuk 3). Hieraan heb ik toegevoegd de aanbevelingen uit recent 
gepubliceerd wetenschappelijk onderzoek en de conclusies van het literatuuronderzoek 
beschreven in hoofdstuk 2. In de volgende stap heb ik Europese zorgverleners en 
dementieonderzoekers laten beoordelen hoe goed deze aanbevelingen bijdragen aan een goede 
kwaliteit van zorg bij dementie. De meest waardevolle aanbevelingen zijn op deze wijze 
geselecteerd en vormden de basis voor de uiteindelijke set van 12 kwaliteitsindicatoren 
(Hoofdstuk 4). De set meet onder andere of patiënten en mantelzorgers psychosociale zorg 
krijgen die is aangepast aan hun wensen en behoeften en of regelmatig wordt nagegaan door 
een vaste zorgverlener of ze nog tevreden zijn met de psychosociale zorg. Als laatste stap heeft 
een groep van 25 Europese zorgverleners en dementieonderzoekers gediscussieerd over factoren 
die van invloed zijn op het invoeren van de set kwaliteitsindicatoren in verschillende Europese 
landen (Hoofdstuk 5). De belangrijkste conclusie hieruit is dat de organisatie van de zorg aan 
dementiepatiënten en mantelzorgers verschilt tussen en binnen landen. De set kwaliteits-
indicatoren kan daarom het beste worden ingevoerd op regionaal niveau, waarbij rekening moet 
worden gehouden met regionale wet- en regelgeving en het scholingsniveau van zorgverleners. 
De set kwaliteitsindicatoren voor psychosociale zorg, beschreven in mijn proefschrift, is nuttig 
voor zowel Europese dementieonderzoekers als zorgverleners. De set geeft onderzoekers de 
mogelijkheid om de kwaliteit van psychosociale zorg bij dementie binnen en tussen Europese 
landen te onderzoeken en te vergelijken. Zorgverleners kunnen de set gebruiken om hun eigen 
kwaliteit van zorg aan dementiepatiënten en mantelzorgers te verbeteren. 
 
Dankwoord 
Voordat ik daadwerkelijk begin met mijn dankwoord, wil ik graag kwijt dat ik me hierin heb 
beperkt tot degenen die inhoudelijk een bijdrage hebben geleverd aan of op een andere manier 
van grote invloed zijn geweest op het schrijven van dit proefschrift. Dus, beste vrienden, familie 
en collega’s, als je hieronder niet genoemd wordt, zegt dat alleen iets over je bijdrage aan mijn 
proefschrift. Het zegt helemaal niets over je bijdrage aan de rest van mijn leven. Ik hoop dat ik 
me zo voldoende ingedekt heb.  
 
Lieve pap en mam, mijn dankwoord begin ik bij jullie. Net als ikzelf hadden jullie tijdens mijn 
jeugd vast niet gedacht dat ik ooit zou gaan promoveren. Jullie goede zorgen hebben een 
belangrijke basis gelegd voor het bereiken van deze mijlpaal. De dagelijkse thee met koekjes en 
het plakken van menig lekke band maakten de schooltijd een stuk aangenamer. Ook tijdens mijn 
studie in Wageningen hebben jullie me geholpen waar mogelijk. Op zondag met de auto gebracht 
i.p.v. met de trein op pad en hulp bij het inrichten van de studentenkamer. 
Ook zijn jullie van nature nieuwsgierig naar wat anderen doen en waarom ze dat dan doen zoals 
ze het doen. De vragen ‘Hoe zit dat dan?’, ‘Waarom dan?’ en ‘Hoe kan dat dan?’ worden vaak 
gesteld. Hoewel ik, Léander en Glenda er wel eens grappen over maken, denk ik dat jullie 
nieuwsgierige houding eraan heeft bijgedragen dat ik in het onderzoek ben beland en 
geïnteresseerd ben in hoe dingen en mensen in elkaar zitten. Ik hoop van harte dat jullie deze 
nieuwsgierigheid nog lang zullen behouden, wie weet steken jullie de kleinkinderen er ook mee 
aan.  
 
Myrra, als het gaat om de inhoud van dit proefschrift ben jij degene die ik het meest dankbaar 
ben. De duur van het EuroCoDe project was bij mijn aanstelling slechts 2,5 jaar en ook nog 
parttime. Dankzij jouw inspanningen is er uiteindelijk heel wat tijd bijgekomen en was het 
mogelijk om een mooi proefschrift bij elkaar te schrijven. Begeleiding op afstand was voor jou 
geen probleem, via Skype leek het net of ik gewoon in je kamer zat. Door het samenwerken met 
jou heb ik veel geleerd over het schrijven van artikelen en het doen van onderzoek. Daarnaast 
heb ik genoten van onze uitstapjes naar verschillende Europese steden en de kennismaking met 
Interdemleden. Ik vind het fijn dat onze samenwerking niet stopt nu het proefschrift af is.  
Marcel, hoewel minder intensief was je begeleiding toch zeker niet minder effectief dan die van 
Myrra. Je snelle en uitgebreide reacties op de vele concepten van artikelen en de discussies over 
het nut van de kwaliteitsindicatoren voor de (medische) praktijk waren erg nuttig en leerzaam. Je 
initiële twijfel over of ik wel echt wilde promoveren heeft er mede voor gezorgd dat ik mij ging 
beseffen dat ik dit inderdaad echt wilde. En zie hier, het proefschrift is af. 
 
Many thanks to the Interdem group and especially those members who were part of the 
EuroCoDe work group. Esme, Bob, Inge, Manuel, Kevin, and Pascale without your help, 
knowledge, and enthusiasm it would have been impossible to develop the set of quality 
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indicators. I enjoyed our meetings in Brussels very much and I hope we will meet again in the 
future. Georgina, you helped me a lot by gathering the data for the Spanish dementia patients 
and with that making it possible to evaluate the set in practice.  
I also would like to thank the many other Interdem members who helped in developing and 
evaluating the set of quality indicators. I appreciated that so many of you travelled to Berlin for 
the consensus meeting and took part in the discussions about the final set of quality indicators. 
You have shown that European collaboration results in positive outcomes as well. 
 
Lieve Rutger, bedankt voor al je steun en toeverlaat, niet alleen bij het schrijven van dit 
proefschrift maar al zolang als ik je ken. Toen ik zelf nog twijfelde of promoveren wel voor mij 
was weggelegd, was jij al overtuigd dat ik het kon. Tijdens mijn stage in Ziekenhuis Gelderse 
Vallei had ik  het druk, heel erg druk. Gelukkig was jij er toen om voor me te zorgen, zodat ik mijn 
aandacht kon verdelen tussen promotie en stage. Ik waardeer het ook enorm dat jij je vol 
overgave op ons nieuwe huis hebt gestort, terwijl ik zwanger op de bank zat en mijn proefschrift 
aan het afronden was. Nu is alles anders, mijn proefschrift af, verhuisd en Kai is er! Tijd om de 
komende jaren van alles te genieten. 
 
Alice, heel erg bedankt dat ik bij jou altijd kon aankloppen voor van alles en nog wat 
werkgerelateerd of gewoon voor een gezellig praatje. Het plannen van afspraken met Myrra en 
Marcel tegelijk was telkens een hele puzzel, waarvoor jij uiteindelijk altijd de oplossing had. Je 
belangstelling voor niet alleen mijn werk maar ook privé heb ik erg gewaardeerd. Gelukkig 
betekent het afronden van mijn proefschrift geen afscheid van IQ. Voorlopig blijf ik je dus 
bestoken met afspraakverzoeken en vragen omtrent procedures op de afdeling waarvoor ik zelf 
te lui ben om ze op te zoeken en waarop jij meteen het antwoord weet. 
  
Doordat ik gegevens mocht verzamelen uit de patiëntdossiers van 67 Nederlandse personen met 
dementie was het voor mij mogelijk om de kwaliteitsindicatoren te testen in de praktijk. Hiervoor 
wil ik de mensen met dementie, mantelzorgers en medewerkers van verpleeg- en 
verzorgingshuis Vitalis Peppelrode in Eindhoven, de dagbehandeling van De Wever in Tilburg, de 
dagbehandeling van stichting De Waalboog in Nijmegen en de geheugenpolikliniek van UMC St 
Radboud heel hartelijk danken. Het verzamelen van de gegevens heeft mij veel geleerd over de 
toepassing van de kwaliteitsindicatoren in de praktijk en het is daarom een belangrijk onderdeel 
van dit proefschrift. 
 
Anouk, Els, Maud, Marisol, Nienke, Carola en Ivonne, weten jullie nog? Vroeger, toen IQ nog 
Kwaliteit van Zorg heette en we samen een kamer deelden? Bedankt, voor al jullie adviezen, 
theeleutmomenten en kletspraatjes als het even niet lukte met werken. Marisol, ik heb vast 
genoteerd in mijn agenda: Marisol promotie, september 2013. 
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Anouk, voor jou een extra bedankt. Jij hebt me een heel eind op weggeholpen met het schrijven 
van de systematische review, mijn eerste artikel. Ik heb dankbaar gebruikgemaakt van je ervaring 
met het schrijven van je eigen review (bij sommigen ook wel bekend als FR). Ook bij het schrijven 
van mijn kwalitatieve artikel heb je me erg geholpen, waarvoor hartelijk dank.  
Carola, ook voor jou een speciaal dankjewel voor het verzamelen van een deel van de data voor 
het testen van de kwaliteitsindicatoren in de praktijk. Fijn dat je dat hebt willen doen voor mij. 
 
Jolanda, jij hebt mij geholpen bij de laatste loodjes van het proefschrift, namelijk zorgen dat ie 
naar de drukker kon. Dit bleek nog een vak apart en ik ben blij dat ik van je jarenlange expertise 
gebruik kon maken. 
 
Allerliefste (schoon)familieleden, mijn ouders heb ik al uitgebreid bedankt en hoewel ik heb 
gezegd dat ik mij zou beperken tot diegenen die iets hebben bijgedragen aan mijn proefschrift, 
maak ik voor jullie graag een uitzondering. Ontspanning in de weekenden is immers belangrijk na 
een drukke werkweek.  
Glenda, Léander en Zwannie bedankt voor alle gezellige weekenden in Nieuwleusen, dagjes weg 
en vakantietripjes. Ik hoop dat er nog vele bij zullen komen in aanwezigheid van de nieuwe 
Vasse-generatie. Glenda, bedankt voor de vele keren dat je voor mij Engelse teksten hebt 
nagekeken op schandalige fouten. Niet iets voor jou zo’n promotie? 
Marry, Henk, Claudia, Kirsten en Stefan ook jullie bedankt voor alle gezellige ontspanning tijdens 
zon-, feest- en vakantiedagen. Er komen er vast nog vele meer. Het is prachtig om te zien hoe blij 
jullie worden van Kai. 
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